Gene Symbol | Gene ID | Gene Info |
---|---|---|
MECP2
|
ENSG00000169057.15 | methyl-CpG binding protein 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_153361761_153361912 | MECP2 | 600 | 0.673387 | 0.91 | 6.3e-04 | Click! |
chrX_153360724_153360973 | MECP2 | 1588 | 0.309340 | 0.82 | 7.2e-03 | Click! |
chrX_153359502_153359972 | MECP2 | 2699 | 0.207258 | 0.78 | 1.3e-02 | Click! |
chrX_153361500_153361693 | MECP2 | 840 | 0.537091 | 0.67 | 5.0e-02 | Click! |
chrX_153360009_153360192 | MECP2 | 2336 | 0.227638 | 0.62 | 7.7e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_159825356_159825507 | 3.60 |
TANC1 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
248 |
0.94 |
chr4_55099358_55099536 | 3.60 |
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
2958 |
0.36 |
chr17_75953936_75954131 | 3.42 |
ENSG00000238898 |
. |
37853 |
0.14 |
chr15_99193531_99193682 | 3.17 |
IGF1R |
insulin-like growth factor 1 receptor |
1333 |
0.47 |
chr15_80987115_80987266 | 3.12 |
ABHD17C |
abhydrolase domain containing 17C |
454 |
0.84 |
chr6_45391046_45391197 | 3.08 |
RUNX2 |
runt-related transcription factor 2 |
899 |
0.52 |
chr15_85113718_85113869 | 3.03 |
UBE2Q2P1 |
ubiquitin-conjugating enzyme E2Q family member 2 pseudogene 1 |
138 |
0.75 |
chr18_12947123_12947564 | 3.00 |
SEH1L |
SEH1-like (S. cerevisiae) |
211 |
0.94 |
chr8_126442398_126442698 | 3.00 |
TRIB1 |
tribbles pseudokinase 1 |
15 |
0.98 |
chr22_41843929_41844303 | 2.97 |
TOB2 |
transducer of ERBB2, 2 |
1089 |
0.43 |
chr17_72984009_72984428 | 2.97 |
CDR2L |
cerebellar degeneration-related protein 2-like |
491 |
0.63 |
chr17_59477041_59477307 | 2.93 |
TBX2 |
T-box 2 |
83 |
0.61 |
chr1_6085938_6086173 | 2.92 |
KCNAB2 |
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
305 |
0.89 |
chr9_133539051_133539202 | 2.87 |
PRDM12 |
PR domain containing 12 |
855 |
0.63 |
chr9_131938596_131938922 | 2.84 |
RP11-247A12.2 |
|
291 |
0.7 |
chr15_76196509_76196759 | 2.83 |
FBXO22 |
F-box protein 22 |
168 |
0.94 |
chr19_17906181_17906543 | 2.81 |
B3GNT3 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 |
396 |
0.78 |
chr11_2165632_2165909 | 2.80 |
IGF2 |
insulin-like growth factor 2 (somatomedin A) |
3302 |
0.13 |
chr21_43638909_43639067 | 2.76 |
ABCG1 |
ATP-binding cassette, sub-family G (WHITE), member 1 |
239 |
0.91 |
chr4_41216359_41216532 | 2.75 |
APBB2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
30 |
0.98 |
chr16_85368819_85368979 | 2.75 |
RP11-680G10.1 |
Uncharacterized protein |
22170 |
0.2 |
chr1_101362038_101362240 | 2.74 |
SLC30A7 |
solute carrier family 30 (zinc transporter), member 7 |
329 |
0.65 |
chr2_222437897_222438131 | 2.72 |
CTD-2308L22.1 |
|
788 |
0.46 |
chr12_53718815_53719001 | 2.62 |
AAAS |
achalasia, adrenocortical insufficiency, alacrimia |
366 |
0.77 |
chr5_14143010_14143209 | 2.62 |
TRIO |
trio Rho guanine nucleotide exchange factor |
702 |
0.82 |
chr1_110163131_110163359 | 2.56 |
AMPD2 |
adenosine monophosphate deaminase 2 |
15 |
0.95 |
chr8_61564342_61564493 | 2.54 |
CHD7 |
chromodomain helicase DNA binding protein 7 |
26920 |
0.22 |
chr11_27494130_27494448 | 2.53 |
LGR4 |
leucine-rich repeat containing G protein-coupled receptor 4 |
4 |
0.95 |
chr7_32981714_32982094 | 2.52 |
RP9P |
retinitis pigmentosa 9 pseudogene |
671 |
0.69 |
chr8_70746638_70746875 | 2.52 |
RP11-159H10.3 |
|
368 |
0.62 |
chr1_9884447_9884716 | 2.51 |
CLSTN1 |
calsyntenin 1 |
3 |
0.98 |
chr10_70320624_70320793 | 2.50 |
TET1 |
tet methylcytosine dioxygenase 1 |
295 |
0.9 |
chr12_107168620_107168771 | 2.49 |
RP11-144F15.1 |
Uncharacterized protein |
1 |
0.76 |
chr6_45390010_45390161 | 2.47 |
RUNX2 |
runt-related transcription factor 2 |
137 |
0.75 |
chr15_40212284_40212453 | 2.47 |
GPR176 |
G protein-coupled receptor 176 |
58 |
0.96 |
chr16_31141784_31142119 | 2.47 |
RP11-388M20.2 |
|
803 |
0.33 |
chr19_38719617_38719865 | 2.45 |
DPF1 |
D4, zinc and double PHD fingers family 1 |
408 |
0.72 |
chr6_128840772_128841021 | 2.45 |
PTPRK |
protein tyrosine phosphatase, receptor type, K |
607 |
0.71 |
chr2_54951777_54951928 | 2.44 |
EML6 |
echinoderm microtubule associated protein like 6 |
173 |
0.96 |
chr8_128750160_128750448 | 2.44 |
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
1827 |
0.46 |
chr1_178511388_178511762 | 2.43 |
C1orf220 |
chromosome 1 open reading frame 220 |
312 |
0.54 |
chr17_78009948_78010145 | 2.43 |
CCDC40 |
coiled-coil domain containing 40 |
389 |
0.47 |
chr8_97506033_97506255 | 2.42 |
SDC2 |
syndecan 2 |
92 |
0.98 |
chr5_98106507_98106658 | 2.42 |
RGMB |
repulsive guidance molecule family member b |
1583 |
0.37 |
chr17_3571582_3571763 | 2.40 |
TAX1BP3 |
Tax1 (human T-cell leukemia virus type I) binding protein 3 |
304 |
0.56 |
chr17_45331535_45331807 | 2.38 |
ITGB3 |
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
408 |
0.78 |
chr8_38325731_38325987 | 2.37 |
FGFR1 |
fibroblast growth factor receptor 1 |
275 |
0.9 |
chr5_178487503_178487654 | 2.36 |
ZNF354C |
zinc finger protein 354C |
162 |
0.96 |
chr17_76355717_76355868 | 2.33 |
SOCS3 |
suppressor of cytokine signaling 3 |
363 |
0.83 |
chr2_20646793_20647016 | 2.33 |
RHOB |
ras homolog family member B |
69 |
0.98 |
chr4_41218538_41218742 | 2.32 |
APBB2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
2005 |
0.34 |
chr22_23623329_23623480 | 2.31 |
ENSG00000240160 |
. |
19146 |
0.16 |
chr21_45586674_45586876 | 2.30 |
AP001055.1 |
|
6805 |
0.15 |
chr7_150065334_150065592 | 2.30 |
REPIN1 |
replication initiator 1 |
94 |
0.82 |
chr11_117666431_117666723 | 2.30 |
DSCAML1 |
Down syndrome cell adhesion molecule like 1 |
1229 |
0.42 |
chr2_106015199_106015419 | 2.30 |
FHL2 |
four and a half LIM domains 2 |
198 |
0.95 |
chr18_19749689_19749991 | 2.30 |
GATA6 |
GATA binding protein 6 |
436 |
0.78 |
chr1_95392133_95392325 | 2.29 |
CNN3 |
calponin 3, acidic |
409 |
0.71 |
chr1_51435046_51435197 | 2.29 |
CDKN2C |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
495 |
0.82 |
chr19_33789048_33789424 | 2.28 |
CTD-2540B15.11 |
|
1604 |
0.26 |
chr19_14664365_14664516 | 2.27 |
TECR |
trans-2,3-enoyl-CoA reductase |
7904 |
0.1 |
chr1_54411728_54411879 | 2.25 |
LRRC42 |
leucine rich repeat containing 42 |
45 |
0.7 |
chr1_29451203_29451371 | 2.24 |
TMEM200B |
transmembrane protein 200B |
840 |
0.62 |
chr5_6634104_6634290 | 2.24 |
SRD5A1 |
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
616 |
0.54 |
chr7_25019482_25019633 | 2.22 |
OSBPL3 |
oxysterol binding protein-like 3 |
203 |
0.96 |
chr11_76777312_76777674 | 2.22 |
CAPN5 |
calpain 5 |
486 |
0.79 |
chr2_73430491_73430710 | 2.22 |
NOTO |
notochord homeobox |
1214 |
0.39 |
chr18_23670867_23671186 | 2.21 |
SS18 |
synovial sarcoma translocation, chromosome 18 |
130 |
0.97 |
chr21_45574089_45574422 | 2.21 |
C21orf33 |
chromosome 21 open reading frame 33 |
18254 |
0.13 |
chr15_40734504_40734655 | 2.21 |
BAHD1 |
bromo adjacent homology domain containing 1 |
1168 |
0.3 |
chr14_95624095_95624246 | 2.21 |
DICER1-AS1 |
DICER1 antisense RNA 1 |
73 |
0.65 |
chr1_208417374_208417525 | 2.20 |
PLXNA2 |
plexin A2 |
216 |
0.97 |
chr9_137217343_137217691 | 2.20 |
RXRA |
retinoid X receptor, alpha |
909 |
0.68 |
chr20_31071945_31072098 | 2.19 |
C20orf112 |
chromosome 20 open reading frame 112 |
636 |
0.72 |
chr17_7255084_7255259 | 2.19 |
KCTD11 |
potassium channel tetramerization domain containing 11 |
37 |
0.9 |
chr6_144607266_144607540 | 2.18 |
UTRN |
utrophin |
566 |
0.83 |
chr4_700142_700371 | 2.17 |
PCGF3 |
polycomb group ring finger 3 |
524 |
0.64 |
chr10_8092737_8093024 | 2.16 |
GATA3 |
GATA binding protein 3 |
3776 |
0.37 |
chr5_175224411_175224631 | 2.16 |
CPLX2 |
complexin 2 |
776 |
0.72 |
chr15_75091609_75091760 | 2.12 |
CSK |
c-src tyrosine kinase |
1429 |
0.27 |
chr15_28341250_28341481 | 2.12 |
OCA2 |
oculocutaneous albinism II |
3074 |
0.36 |
chrX_73640577_73640728 | 2.11 |
SLC16A2 |
solute carrier family 16, member 2 (thyroid hormone transporter) |
433 |
0.84 |
chr11_124933206_124933357 | 2.10 |
SLC37A2 |
solute carrier family 37 (glucose-6-phosphate transporter), member 2 |
49 |
0.98 |
chr10_118500862_118501013 | 2.10 |
HSPA12A |
heat shock 70kDa protein 12A |
1148 |
0.55 |
chr4_77227931_77228082 | 2.10 |
FAM47E-STBD1 |
FAM47E-STBD1 readthrough |
827 |
0.62 |
chr6_154831638_154831789 | 2.10 |
CNKSR3 |
CNKSR family member 3 |
80 |
0.99 |
chr21_16437540_16437691 | 2.09 |
NRIP1 |
nuclear receptor interacting protein 1 |
294 |
0.94 |
chr7_5467788_5467939 | 2.09 |
TNRC18 |
trinucleotide repeat containing 18 |
2818 |
0.2 |
chr12_118541417_118541600 | 2.09 |
VSIG10 |
V-set and immunoglobulin domain containing 10 |
201 |
0.94 |
chr11_67158907_67159111 | 2.08 |
RAD9A |
RAD9 homolog A (S. pombe) |
414 |
0.63 |
chr11_32915288_32915493 | 2.08 |
QSER1 |
glutamine and serine rich 1 |
666 |
0.76 |
chr17_46687714_46688061 | 2.08 |
HOXB7 |
homeobox B7 |
492 |
0.55 |
chr1_148176301_148176452 | 2.07 |
PPIAL4D |
peptidylprolyl isomerase A (cyclophilin A)-like 4D |
26160 |
0.21 |
chr11_117694194_117694498 | 2.07 |
FXYD2 |
FXYD domain containing ion transport regulator 2 |
1113 |
0.39 |
chr19_2288228_2288485 | 2.06 |
LINGO3 |
leucine rich repeat and Ig domain containing 3 |
3667 |
0.1 |
chr8_12989596_12990152 | 2.06 |
DLC1 |
deleted in liver cancer 1 |
1109 |
0.58 |
chr9_134127671_134127998 | 2.05 |
FAM78A |
family with sequence similarity 78, member A |
18046 |
0.15 |
chr9_114361618_114361849 | 2.04 |
PTGR1 |
prostaglandin reductase 1 |
46 |
0.97 |
chr19_911759_911910 | 2.03 |
R3HDM4 |
R3H domain containing 4 |
1397 |
0.21 |
chr7_19156075_19156556 | 2.02 |
TWIST1 |
twist family bHLH transcription factor 1 |
980 |
0.47 |
chr10_92617982_92618183 | 2.02 |
HTR7 |
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
411 |
0.84 |
chr4_77870440_77870591 | 2.02 |
SEPT11 |
septin 11 |
341 |
0.91 |
chr9_116638915_116639161 | 2.01 |
ZNF618 |
zinc finger protein 618 |
408 |
0.9 |
chr7_132260829_132261020 | 2.01 |
PLXNA4 |
plexin A4 |
305 |
0.94 |
chr6_1609968_1610177 | 2.00 |
FOXC1 |
forkhead box C1 |
609 |
0.84 |
chr16_8963534_8963725 | 2.00 |
RP11-77H9.6 |
|
521 |
0.53 |
chr22_29702541_29702778 | 2.00 |
GAS2L1 |
growth arrest-specific 2 like 1 |
19 |
0.96 |
chr6_83073422_83073664 | 1.99 |
TPBG |
trophoblast glycoprotein |
195 |
0.97 |
chr2_33171647_33171871 | 1.99 |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
280 |
0.87 |
chr17_79370300_79370599 | 1.99 |
RP11-1055B8.6 |
Uncharacterized protein |
1174 |
0.33 |
chr8_53626326_53626477 | 1.98 |
RB1CC1 |
RB1-inducible coiled-coil 1 |
582 |
0.8 |
chr7_155259797_155259954 | 1.98 |
EN2 |
engrailed homeobox 2 |
9051 |
0.2 |
chr9_37027132_37027283 | 1.98 |
PAX5 |
paired box 5 |
6821 |
0.21 |
chr6_37665222_37665411 | 1.97 |
MDGA1 |
MAM domain containing glycosylphosphatidylinositol anchor 1 |
450 |
0.88 |
chr14_23450790_23450996 | 1.97 |
AJUBA |
ajuba LIM protein |
98 |
0.82 |
chr3_150128529_150128680 | 1.97 |
TSC22D2 |
TSC22 domain family, member 2 |
152 |
0.97 |
chr17_40828708_40828871 | 1.97 |
PLEKHH3 |
pleckstrin homology domain containing, family H (with MyTH4 domain) member 3 |
180 |
0.87 |
chr1_72747716_72747902 | 1.96 |
NEGR1 |
neuronal growth regulator 1 |
362 |
0.94 |
chr17_42298747_42298947 | 1.96 |
RP5-882C2.2 |
|
78 |
0.58 |
chr11_46299587_46299738 | 1.96 |
CREB3L1 |
cAMP responsive element binding protein 3-like 1 |
434 |
0.81 |
chr10_70166213_70166490 | 1.96 |
RUFY2 |
RUN and FYVE domain containing 2 |
595 |
0.72 |
chr1_107682967_107683366 | 1.95 |
NTNG1 |
netrin G1 |
276 |
0.95 |
chr17_47572813_47573046 | 1.95 |
NGFR |
nerve growth factor receptor |
274 |
0.9 |
chr6_17281962_17282243 | 1.95 |
RBM24 |
RNA binding motif protein 24 |
166 |
0.97 |
chr8_67342050_67342201 | 1.94 |
ADHFE1 |
alcohol dehydrogenase, iron containing, 1 |
295 |
0.81 |
chr16_374596_375006 | 1.93 |
AXIN1 |
axin 1 |
27648 |
0.08 |
chr12_49208863_49209014 | 1.92 |
CACNB3 |
calcium channel, voltage-dependent, beta 3 subunit |
432 |
0.7 |
chr1_33168008_33168162 | 1.92 |
SYNC |
syncoilin, intermediate filament protein |
276 |
0.88 |
chr8_48649021_48649217 | 1.91 |
CEBPD |
CCAAT/enhancer binding protein (C/EBP), delta |
2529 |
0.27 |
chr21_35779982_35780133 | 1.91 |
C21orf140 |
chromosome 21 open reading frame 140 |
6687 |
0.14 |
chr9_131182814_131182965 | 1.91 |
CERCAM |
cerebral endothelial cell adhesion molecule |
129 |
0.93 |
chr11_10316294_10316621 | 1.90 |
SBF2 |
SET binding factor 2 |
703 |
0.64 |
chr1_223900718_223900927 | 1.90 |
CAPN2 |
calpain 2, (m/II) large subunit |
788 |
0.67 |
chr1_40943183_40943379 | 1.89 |
ZFP69 |
ZFP69 zinc finger protein |
21 |
0.96 |
chr10_126850115_126850433 | 1.89 |
CTBP2 |
C-terminal binding protein 2 |
644 |
0.82 |
chr4_81118406_81118599 | 1.89 |
PRDM8 |
PR domain containing 8 |
156 |
0.96 |
chr4_114900887_114901047 | 1.88 |
ARSJ |
arylsulfatase family, member J |
110 |
0.98 |
chr17_79213668_79213930 | 1.88 |
C17orf89 |
chromosome 17 open reading frame 89 |
388 |
0.65 |
chr6_86159556_86159707 | 1.88 |
NT5E |
5'-nucleotidase, ecto (CD73) |
178 |
0.97 |
chr17_72869588_72869881 | 1.88 |
FDXR |
ferredoxin reductase |
578 |
0.62 |
chr7_155249926_155250111 | 1.87 |
EN2 |
engrailed homeobox 2 |
806 |
0.65 |
chr5_9545938_9546089 | 1.87 |
SEMA5A |
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
174 |
0.95 |
chr9_138999867_139000258 | 1.87 |
C9orf69 |
chromosome 9 open reading frame 69 |
10058 |
0.19 |
chr3_110791222_110791418 | 1.87 |
PVRL3 |
poliovirus receptor-related 3 |
305 |
0.83 |
chr4_3294031_3294438 | 1.87 |
RGS12 |
regulator of G-protein signaling 12 |
16528 |
0.22 |
chr9_92220151_92220341 | 1.87 |
GADD45G |
growth arrest and DNA-damage-inducible, gamma |
293 |
0.94 |
chr1_29450638_29450874 | 1.87 |
TMEM200B |
transmembrane protein 200B |
309 |
0.9 |
chr10_25013530_25013681 | 1.86 |
ARHGAP21 |
Rho GTPase activating protein 21 |
1008 |
0.67 |
chr3_184286763_184286975 | 1.86 |
EPHB3 |
EPH receptor B3 |
7297 |
0.2 |
chr11_76494373_76494524 | 1.86 |
TSKU |
tsukushi, small leucine rich proteoglycan |
165 |
0.7 |
chr19_3506881_3507063 | 1.86 |
FZR1 |
fizzy/cell division cycle 20 related 1 (Drosophila) |
701 |
0.48 |
chr1_200983118_200983269 | 1.86 |
KIF21B |
kinesin family member 21B |
9343 |
0.19 |
chr12_57521749_57522080 | 1.86 |
LRP1 |
low density lipoprotein receptor-related protein 1 |
362 |
0.68 |
chr19_54982835_54983019 | 1.85 |
CDC42EP5 |
CDC42 effector protein (Rho GTPase binding) 5 |
1484 |
0.22 |
chr4_141074126_141074317 | 1.85 |
MAML3 |
mastermind-like 3 (Drosophila) |
98 |
0.98 |
chr8_72756498_72756649 | 1.85 |
MSC |
musculin |
130 |
0.91 |
chr4_55098233_55098384 | 1.85 |
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
1819 |
0.47 |
chr1_26202251_26202402 | 1.84 |
ENSG00000207302 |
. |
1661 |
0.19 |
chr19_18221254_18221431 | 1.84 |
IL12RB1 |
interleukin 12 receptor, beta 1 |
11588 |
0.12 |
chr2_45879608_45879952 | 1.84 |
PRKCE |
protein kinase C, epsilon |
867 |
0.64 |
chr9_131965349_131965516 | 1.83 |
RP11-247A12.2 |
|
1838 |
0.27 |
chr5_158525970_158526185 | 1.83 |
EBF1 |
early B-cell factor 1 |
624 |
0.8 |
chr5_180017462_180017735 | 1.83 |
SCGB3A1 |
secretoglobin, family 3A, member 1 |
942 |
0.54 |
chr2_171568724_171569013 | 1.83 |
LINC01124 |
long intergenic non-protein coding RNA 1124 |
2209 |
0.25 |
chr17_74070568_74070719 | 1.83 |
GALR2 |
galanin receptor 2 |
232 |
0.85 |
chr14_23306140_23306484 | 1.82 |
MMP14 |
matrix metallopeptidase 14 (membrane-inserted) |
209 |
0.85 |
chr3_183967629_183968023 | 1.82 |
ECE2 |
endothelin converting enzyme 2 |
343 |
0.55 |
chr5_153569731_153569882 | 1.82 |
GALNT10 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (GalNAc-T10) |
484 |
0.86 |
chr11_86665978_86666264 | 1.81 |
FZD4 |
frizzled family receptor 4 |
312 |
0.92 |
chr19_41812316_41812501 | 1.81 |
CCDC97 |
coiled-coil domain containing 97 |
3686 |
0.14 |
chr11_63535181_63535583 | 1.80 |
ENSG00000264519 |
. |
30161 |
0.13 |
chr19_42830156_42830338 | 1.80 |
MEGF8 |
multiple EGF-like-domains 8 |
149 |
0.91 |
chr12_54520171_54520436 | 1.80 |
ENSG00000202146 |
. |
27217 |
0.09 |
chr9_139947893_139948114 | 1.80 |
ENTPD2 |
ectonucleoside triphosphate diphosphohydrolase 2 |
467 |
0.43 |
chr7_106300505_106300656 | 1.79 |
CCDC71L |
coiled-coil domain containing 71-like |
862 |
0.68 |
chr17_5025884_5026035 | 1.79 |
ZNF232 |
zinc finger protein 232 |
438 |
0.71 |
chr10_135054594_135055053 | 1.79 |
VENTX |
VENT homeobox |
3915 |
0.13 |
chr17_71640204_71640498 | 1.79 |
SDK2 |
sidekick cell adhesion molecule 2 |
123 |
0.97 |
chr20_58515239_58515390 | 1.79 |
PPP1R3D |
protein phosphatase 1, regulatory subunit 3D |
38 |
0.68 |
chr10_93647157_93647411 | 1.78 |
RP11-402D21.2 |
|
20604 |
0.17 |
chr4_170191692_170191843 | 1.78 |
SH3RF1 |
SH3 domain containing ring finger 1 |
233 |
0.96 |
chr1_223744344_223744507 | 1.78 |
CAPN8 |
calpain 8 |
20045 |
0.25 |
chr1_57043982_57044133 | 1.78 |
PPAP2B |
phosphatidic acid phosphatase type 2B |
1184 |
0.62 |
chr11_1863672_1864036 | 1.78 |
TNNI2 |
troponin I type 2 (skeletal, fast) |
2430 |
0.15 |
chr18_907938_908174 | 1.78 |
RP11-672L10.3 |
|
375 |
0.78 |
chr2_70141540_70141717 | 1.78 |
MXD1 |
MAX dimerization protein 1 |
575 |
0.61 |
chr13_37393640_37393791 | 1.78 |
RFXAP |
regulatory factor X-associated protein |
354 |
0.89 |
chr1_184005410_184005648 | 1.77 |
COLGALT2 |
collagen beta(1-O)galactosyltransferase 2 |
1082 |
0.59 |
chr19_34311165_34311316 | 1.77 |
KCTD15 |
potassium channel tetramerization domain containing 15 |
13411 |
0.27 |
chr12_30949307_30949506 | 1.76 |
CAPRIN2 |
caprin family member 2 |
41521 |
0.19 |
chr9_139025848_139026088 | 1.76 |
C9orf69 |
chromosome 9 open reading frame 69 |
15237 |
0.18 |
chr17_76879982_76880133 | 1.76 |
TIMP2 |
TIMP metallopeptidase inhibitor 2 |
9825 |
0.14 |
chr12_49688966_49689117 | 1.76 |
PRPH |
peripherin |
104 |
0.94 |
chr17_72983839_72983990 | 1.76 |
CDR2L |
cerebellar degeneration-related protein 2-like |
187 |
0.88 |
chr15_73977075_73977431 | 1.76 |
CD276 |
CD276 molecule |
94 |
0.98 |
chr8_61564676_61564827 | 1.75 |
CHD7 |
chromodomain helicase DNA binding protein 7 |
26586 |
0.22 |
chr2_239335784_239335935 | 1.75 |
ASB1 |
ankyrin repeat and SOCS box containing 1 |
214 |
0.76 |
chrX_44731810_44731961 | 1.74 |
KDM6A |
lysine (K)-specific demethylase 6A |
872 |
0.62 |
chr2_202507689_202507877 | 1.74 |
TMEM237 |
transmembrane protein 237 |
116 |
0.96 |
chr5_71403276_71403541 | 1.74 |
MAP1B |
microtubule-associated protein 1B |
95 |
0.98 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 14.9 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
1.9 | 1.9 | GO:0021978 | telencephalon regionalization(GO:0021978) |
1.8 | 5.3 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
1.7 | 5.1 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
1.6 | 4.9 | GO:0060430 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
1.6 | 3.3 | GO:0072160 | nephron tubule epithelial cell differentiation(GO:0072160) regulation of nephron tubule epithelial cell differentiation(GO:0072182) regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
1.6 | 4.7 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
1.5 | 1.5 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.5 | 6.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.5 | 4.5 | GO:0060596 | mammary placode formation(GO:0060596) |
1.5 | 4.5 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.5 | 3.0 | GO:0050919 | negative chemotaxis(GO:0050919) |
1.5 | 2.9 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
1.5 | 4.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
1.4 | 4.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.4 | 4.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.4 | 11.3 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
1.4 | 5.5 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
1.4 | 4.1 | GO:1900116 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
1.3 | 3.9 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.3 | 3.9 | GO:0010761 | fibroblast migration(GO:0010761) |
1.3 | 3.9 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
1.3 | 3.8 | GO:0045901 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
1.3 | 1.3 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
1.2 | 3.7 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
1.2 | 3.7 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
1.2 | 3.6 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
1.2 | 3.6 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
1.2 | 2.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.2 | 3.6 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.2 | 3.6 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
1.2 | 1.2 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
1.2 | 5.8 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.1 | 11.3 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
1.1 | 4.5 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
1.1 | 3.4 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
1.1 | 6.6 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
1.1 | 2.2 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
1.1 | 1.1 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
1.1 | 3.3 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
1.1 | 8.6 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
1.1 | 1.1 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
1.1 | 2.1 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) |
1.0 | 2.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
1.0 | 3.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
1.0 | 3.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
1.0 | 3.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
1.0 | 7.0 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
1.0 | 3.0 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
1.0 | 1.0 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
1.0 | 3.9 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
1.0 | 1.0 | GO:0009620 | response to fungus(GO:0009620) |
1.0 | 3.9 | GO:0021571 | rhombomere 5 development(GO:0021571) |
1.0 | 4.9 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.9 | 3.8 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.9 | 3.8 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.9 | 2.8 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) positive regulation of gamma-delta T cell differentiation(GO:0045588) |
0.9 | 3.7 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.9 | 3.6 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.9 | 1.8 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.9 | 1.8 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.9 | 2.7 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.9 | 2.7 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.9 | 2.7 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.9 | 0.9 | GO:2000328 | T-helper cell lineage commitment(GO:0002295) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) memory T cell differentiation(GO:0043379) regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) T-helper 17 type immune response(GO:0072538) T-helper 17 cell differentiation(GO:0072539) T-helper 17 cell lineage commitment(GO:0072540) regulation of T-helper 17 type immune response(GO:2000316) positive regulation of T-helper 17 type immune response(GO:2000318) regulation of T-helper 17 cell differentiation(GO:2000319) positive regulation of T-helper 17 cell differentiation(GO:2000321) regulation of T-helper 17 cell lineage commitment(GO:2000328) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
0.9 | 2.6 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.9 | 0.9 | GO:2000380 | regulation of mesodermal cell fate specification(GO:0042661) regulation of mesoderm development(GO:2000380) negative regulation of gastrulation(GO:2000542) |
0.9 | 3.5 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.9 | 3.5 | GO:0008218 | bioluminescence(GO:0008218) |
0.9 | 2.6 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.9 | 0.9 | GO:0043301 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
0.9 | 2.6 | GO:1903960 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.8 | 2.5 | GO:0007144 | female meiosis I(GO:0007144) |
0.8 | 4.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.8 | 1.7 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.8 | 3.4 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.8 | 4.2 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.8 | 2.5 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.8 | 0.8 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.8 | 2.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.8 | 2.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.8 | 2.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.8 | 0.8 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.8 | 2.4 | GO:0046449 | allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.8 | 2.4 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.8 | 2.4 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.8 | 5.5 | GO:0031000 | response to caffeine(GO:0031000) |
0.8 | 1.6 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.8 | 5.5 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.8 | 1.6 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.8 | 4.7 | GO:0031274 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.8 | 2.3 | GO:0046137 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.8 | 2.3 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.8 | 0.8 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.8 | 2.3 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.8 | 3.1 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.8 | 3.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.8 | 0.8 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.8 | 3.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.8 | 1.5 | GO:0003181 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
0.8 | 1.5 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.7 | 3.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.7 | 0.7 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.7 | 4.5 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.7 | 0.7 | GO:0021754 | facial nucleus development(GO:0021754) |
0.7 | 0.7 | GO:0040029 | regulation of gene expression, epigenetic(GO:0040029) |
0.7 | 0.7 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.7 | 0.7 | GO:0048541 | Peyer's patch development(GO:0048541) |
0.7 | 1.5 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.7 | 2.2 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.7 | 0.7 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.7 | 0.7 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.7 | 2.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.7 | 0.7 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.7 | 2.9 | GO:0002551 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.7 | 0.7 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.7 | 2.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.7 | 2.2 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.7 | 2.2 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.7 | 3.6 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.7 | 1.4 | GO:0001508 | action potential(GO:0001508) |
0.7 | 2.1 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.7 | 3.6 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.7 | 2.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.7 | 1.4 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.7 | 2.8 | GO:0051642 | centrosome localization(GO:0051642) |
0.7 | 0.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.7 | 4.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.7 | 2.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.7 | 1.4 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.7 | 4.9 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.7 | 1.4 | GO:0008615 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.7 | 3.5 | GO:0003337 | mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003337) metanephric renal vesicle morphogenesis(GO:0072283) |
0.7 | 2.8 | GO:0008366 | ensheathment of neurons(GO:0007272) axon ensheathment(GO:0008366) |
0.7 | 2.8 | GO:0031297 | replication fork processing(GO:0031297) |
0.7 | 1.4 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.7 | 0.7 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.7 | 0.7 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.7 | 2.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.7 | 2.0 | GO:0001705 | ectoderm formation(GO:0001705) |
0.7 | 3.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.7 | 0.7 | GO:0046040 | IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
0.7 | 0.7 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.7 | 0.7 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.7 | 1.3 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.7 | 0.7 | GO:0072091 | regulation of stem cell proliferation(GO:0072091) |
0.7 | 2.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.7 | 2.0 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.7 | 1.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.7 | 2.0 | GO:0046398 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
0.6 | 1.9 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.6 | 2.6 | GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043122) |
0.6 | 3.8 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.6 | 2.5 | GO:0060347 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.6 | 1.9 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.6 | 1.3 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.6 | 1.9 | GO:0030091 | protein repair(GO:0030091) |
0.6 | 3.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.6 | 1.9 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.6 | 1.9 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.6 | 2.5 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.6 | 1.9 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.6 | 2.5 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.6 | 1.2 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.6 | 2.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.6 | 0.6 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.6 | 0.6 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.6 | 1.2 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.6 | 2.4 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.6 | 3.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.6 | 1.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.6 | 1.8 | GO:0018243 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.6 | 3.6 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.6 | 0.6 | GO:0031333 | negative regulation of protein complex assembly(GO:0031333) |
0.6 | 1.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.6 | 0.6 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.6 | 3.0 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.6 | 2.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.6 | 1.2 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.6 | 1.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.6 | 1.8 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.6 | 2.4 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.6 | 1.2 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.6 | 3.6 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.6 | 0.6 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.6 | 1.8 | GO:0010842 | retina layer formation(GO:0010842) |
0.6 | 0.6 | GO:0072178 | nephric duct morphogenesis(GO:0072178) mesonephric duct morphogenesis(GO:0072180) |
0.6 | 0.6 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.6 | 2.3 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.6 | 2.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.6 | 0.6 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.6 | 1.7 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.6 | 3.5 | GO:0060009 | Sertoli cell differentiation(GO:0060008) Sertoli cell development(GO:0060009) |
0.6 | 1.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.6 | 0.6 | GO:0030432 | peristalsis(GO:0030432) |
0.6 | 0.6 | GO:0016241 | regulation of macroautophagy(GO:0016241) |
0.6 | 1.1 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.6 | 4.0 | GO:0006560 | proline metabolic process(GO:0006560) |
0.6 | 0.6 | GO:0060437 | lung growth(GO:0060437) |
0.6 | 2.9 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.6 | 1.7 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) epithelial cell proliferation involved in lung morphogenesis(GO:0060502) regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.6 | 0.6 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.6 | 1.7 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.6 | 2.8 | GO:0046546 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.6 | 1.7 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.6 | 1.7 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.6 | 2.3 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
0.6 | 0.6 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.6 | 2.3 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) positive regulation of protein kinase A signaling(GO:0010739) |
0.6 | 0.6 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.6 | 0.6 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.6 | 0.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.6 | 2.2 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.6 | 5.0 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.6 | 1.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.5 | 1.6 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.5 | 2.2 | GO:0002686 | negative regulation of leukocyte migration(GO:0002686) |
0.5 | 2.7 | GO:0080111 | DNA demethylation(GO:0080111) |
0.5 | 0.5 | GO:0010159 | specification of organ position(GO:0010159) |
0.5 | 2.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.5 | 1.1 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.5 | 0.5 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.5 | 2.7 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.5 | 1.6 | GO:0021702 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.5 | 1.6 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.5 | 2.7 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.5 | 2.2 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.5 | 3.2 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.5 | 0.5 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.5 | 0.5 | GO:0043090 | amino acid import(GO:0043090) |
0.5 | 2.7 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.5 | 2.7 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.5 | 1.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.5 | 1.6 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.5 | 1.1 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
0.5 | 1.6 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.5 | 1.1 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.5 | 1.1 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.5 | 0.5 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.5 | 1.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.5 | 5.2 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.5 | 2.1 | GO:0050685 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.5 | 2.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.5 | 1.5 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.5 | 1.5 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.5 | 1.0 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.5 | 3.6 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.5 | 7.6 | GO:0016575 | histone deacetylation(GO:0016575) |
0.5 | 5.6 | GO:0031648 | protein destabilization(GO:0031648) |
0.5 | 2.0 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.5 | 2.0 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.5 | 1.0 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.5 | 1.0 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.5 | 1.5 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.5 | 1.0 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.5 | 2.0 | GO:0072583 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.5 | 0.5 | GO:0045843 | negative regulation of striated muscle tissue development(GO:0045843) negative regulation of muscle tissue development(GO:1901862) |
0.5 | 3.0 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.5 | 3.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.5 | 1.5 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.5 | 1.5 | GO:0032661 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
0.5 | 2.0 | GO:0060179 | male mating behavior(GO:0060179) |
0.5 | 0.5 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.5 | 1.5 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.5 | 1.5 | GO:0045056 | transcytosis(GO:0045056) |
0.5 | 1.5 | GO:0019511 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.5 | 5.3 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.5 | 0.5 | GO:0032535 | regulation of cellular component size(GO:0032535) |
0.5 | 1.9 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.5 | 2.4 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.5 | 1.4 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.5 | 2.4 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.5 | 3.8 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.5 | 6.7 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.5 | 5.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.5 | 1.4 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.5 | 0.5 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.5 | 1.4 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.5 | 0.9 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.5 | 2.4 | GO:0008354 | germ cell migration(GO:0008354) |
0.5 | 3.8 | GO:0001706 | endoderm formation(GO:0001706) |
0.5 | 0.5 | GO:0035264 | multicellular organism growth(GO:0035264) |
0.5 | 1.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.5 | 1.9 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.5 | 0.9 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.5 | 2.8 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.5 | 1.4 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.5 | 2.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.5 | 2.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.5 | 0.9 | GO:0003407 | neural retina development(GO:0003407) |
0.5 | 1.4 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.5 | 1.8 | GO:0010107 | potassium ion import(GO:0010107) |
0.5 | 0.9 | GO:0032060 | bleb assembly(GO:0032060) |
0.5 | 0.9 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.5 | 3.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.5 | 1.8 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.5 | 0.9 | GO:0048864 | stem cell development(GO:0048864) |
0.5 | 0.9 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.5 | 1.8 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.4 | 0.4 | GO:0014044 | Schwann cell development(GO:0014044) myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.4 | 1.3 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.4 | 1.3 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.4 | 0.4 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.4 | 0.9 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.4 | 0.4 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.4 | 0.4 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.4 | 2.2 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.4 | 3.1 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.4 | 2.7 | GO:0044782 | cilium assembly(GO:0042384) cilium organization(GO:0044782) |
0.4 | 2.7 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.4 | 4.0 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.4 | 6.2 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.4 | 1.3 | GO:0032355 | response to estradiol(GO:0032355) |
0.4 | 1.3 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.4 | 0.9 | GO:0034332 | adherens junction organization(GO:0034332) |
0.4 | 1.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.4 | 0.9 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.4 | 8.3 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.4 | 1.7 | GO:0018101 | protein citrullination(GO:0018101) |
0.4 | 1.7 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.4 | 1.7 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.4 | 1.7 | GO:0045830 | positive regulation of isotype switching(GO:0045830) positive regulation of DNA recombination(GO:0045911) |
0.4 | 0.4 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.4 | 1.7 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 1.7 | GO:0042246 | tissue regeneration(GO:0042246) |
0.4 | 2.2 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.4 | 0.4 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
0.4 | 2.1 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.4 | 0.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.4 | 1.7 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.4 | 1.3 | GO:0032368 | regulation of lipid transport(GO:0032368) |
0.4 | 2.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.4 | 1.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 3.4 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.4 | 0.8 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.4 | 2.1 | GO:0001945 | lymph vessel development(GO:0001945) |
0.4 | 0.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.4 | 0.8 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.4 | 2.1 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.4 | 0.4 | GO:0002063 | chondrocyte development(GO:0002063) |
0.4 | 2.9 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.4 | 3.7 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.4 | 2.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.4 | 2.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.4 | 0.8 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.4 | 0.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.4 | 0.8 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.4 | 0.8 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.4 | 1.6 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.4 | 0.8 | GO:0060438 | trachea development(GO:0060438) |
0.4 | 2.0 | GO:0060004 | reflex(GO:0060004) |
0.4 | 1.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.4 | 1.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.4 | 1.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.4 | 2.4 | GO:0006983 | ER overload response(GO:0006983) |
0.4 | 0.4 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) |
0.4 | 0.8 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.4 | 1.6 | GO:0001820 | serotonin secretion(GO:0001820) |
0.4 | 1.6 | GO:0036473 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.4 | 0.8 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.4 | 0.4 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.4 | 2.0 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.4 | 0.4 | GO:0003159 | morphogenesis of an endothelium(GO:0003159) |
0.4 | 2.8 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.4 | 1.6 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.4 | 2.4 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.4 | 1.6 | GO:0007530 | sex determination(GO:0007530) |
0.4 | 1.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.4 | 1.6 | GO:0046618 | drug export(GO:0046618) |
0.4 | 3.6 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.4 | 1.2 | GO:0050821 | protein stabilization(GO:0050821) |
0.4 | 0.8 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.4 | 2.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.4 | 4.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.4 | 0.4 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.4 | 1.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.4 | 0.4 | GO:0021591 | ventricular system development(GO:0021591) |
0.4 | 2.0 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.4 | 4.3 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.4 | 1.2 | GO:0051017 | actin filament bundle assembly(GO:0051017) actin filament bundle organization(GO:0061572) |
0.4 | 1.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.4 | 1.6 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.4 | 1.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.4 | 0.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.4 | 2.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.4 | 2.3 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.4 | 1.5 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.4 | 0.8 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.4 | 1.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.4 | 2.7 | GO:0001776 | leukocyte homeostasis(GO:0001776) |
0.4 | 1.1 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.4 | 1.5 | GO:0031641 | regulation of myelination(GO:0031641) |
0.4 | 2.6 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.4 | 1.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.4 | 0.8 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.4 | 1.9 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.4 | 1.9 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.4 | 2.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.4 | 0.7 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.4 | 0.4 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) negative regulation of actin filament depolymerization(GO:0030835) |
0.4 | 0.4 | GO:0021602 | cranial nerve morphogenesis(GO:0021602) |
0.4 | 5.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.4 | 0.7 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.4 | 0.7 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.4 | 2.9 | GO:0007567 | parturition(GO:0007567) |
0.4 | 0.4 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.4 | 1.1 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.4 | 1.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 1.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.4 | 2.9 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.4 | 0.7 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.4 | 1.1 | GO:2001234 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.4 | 0.7 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.4 | 0.4 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.4 | 0.7 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.4 | 0.4 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.4 | 1.5 | GO:1903078 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.4 | 2.9 | GO:0007172 | signal complex assembly(GO:0007172) |
0.4 | 1.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.4 | 1.4 | GO:0002098 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.4 | 4.3 | GO:0006385 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
0.4 | 1.4 | GO:0032816 | positive regulation of natural killer cell activation(GO:0032816) |
0.4 | 1.1 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.4 | 0.7 | GO:0015816 | glycine transport(GO:0015816) |
0.4 | 1.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.4 | 1.1 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.4 | 0.4 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.4 | 0.4 | GO:0016458 | gene silencing(GO:0016458) |
0.4 | 7.8 | GO:0046847 | filopodium assembly(GO:0046847) |
0.4 | 1.1 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.4 | 2.8 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.4 | 1.8 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.4 | 1.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.4 | 1.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.4 | 0.7 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.4 | 0.4 | GO:0072698 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.4 | 0.4 | GO:0032747 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.4 | 1.8 | GO:0030903 | notochord development(GO:0030903) |
0.3 | 1.4 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.3 | 1.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 4.5 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) |
0.3 | 2.8 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.3 | 0.3 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.3 | 1.4 | GO:0008347 | glial cell migration(GO:0008347) |
0.3 | 0.3 | GO:0009299 | mRNA transcription(GO:0009299) |
0.3 | 4.5 | GO:0030901 | midbrain development(GO:0030901) |
0.3 | 1.7 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.3 | 2.1 | GO:0048103 | somatic stem cell division(GO:0048103) |
0.3 | 1.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.3 | 1.4 | GO:0002467 | germinal center formation(GO:0002467) |
0.3 | 2.0 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.3 | 4.4 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.3 | 0.7 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.3 | 4.4 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.3 | 0.7 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.3 | 1.7 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.3 | 2.0 | GO:0010324 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.3 | 2.0 | GO:0030163 | protein catabolic process(GO:0030163) |
0.3 | 1.0 | GO:0000478 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) cleavage involved in rRNA processing(GO:0000469) endonucleolytic cleavage involved in rRNA processing(GO:0000478) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) maturation of SSU-rRNA(GO:0030490) RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.3 | 5.0 | GO:0007140 | male meiosis(GO:0007140) |
0.3 | 1.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 2.0 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.3 | 1.3 | GO:0014020 | primary neural tube formation(GO:0014020) |
0.3 | 2.0 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.3 | 0.3 | GO:0051668 | receptor clustering(GO:0043113) localization within membrane(GO:0051668) |
0.3 | 1.0 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.3 | 0.3 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.3 | 2.0 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.3 | 0.3 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.3 | 1.6 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.3 | 0.3 | GO:0090200 | positive regulation of mitochondrion organization(GO:0010822) positive regulation of release of cytochrome c from mitochondria(GO:0090200) positive regulation of apoptotic signaling pathway(GO:2001235) |
0.3 | 1.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.3 | 0.7 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.3 | 1.0 | GO:0007569 | cell aging(GO:0007569) |
0.3 | 1.3 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.3 | 2.0 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.3 | 0.7 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.3 | 0.3 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.3 | 1.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 1.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 1.0 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.3 | 1.9 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.3 | 1.3 | GO:0010288 | response to lead ion(GO:0010288) |
0.3 | 1.0 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.3 | 1.9 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.3 | 2.3 | GO:0035195 | gene silencing by miRNA(GO:0035195) |
0.3 | 2.9 | GO:0051322 | anaphase(GO:0051322) |
0.3 | 1.0 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.3 | 1.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.3 | 1.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 0.3 | GO:1990267 | response to transition metal nanoparticle(GO:1990267) |
0.3 | 1.0 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.3 | 5.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 1.0 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.3 | 1.0 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.3 | 0.6 | GO:0036336 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.3 | 1.0 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.3 | 2.5 | GO:0010165 | response to X-ray(GO:0010165) |
0.3 | 2.9 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
0.3 | 1.3 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.3 | 12.9 | GO:0030041 | actin filament polymerization(GO:0030041) |
0.3 | 2.2 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.3 | 1.9 | GO:0042255 | ribosome assembly(GO:0042255) |
0.3 | 0.9 | GO:0016093 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.3 | 6.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.3 | 2.5 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.3 | 0.3 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.3 | 0.9 | GO:0071436 | sodium ion export(GO:0071436) |
0.3 | 1.6 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.3 | 0.9 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.3 | 1.2 | GO:0048332 | mesoderm morphogenesis(GO:0048332) |
0.3 | 2.2 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.3 | 2.8 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.3 | 1.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.3 | 0.3 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.3 | 1.2 | GO:0043247 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.3 | 0.3 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.3 | 1.5 | GO:0050957 | equilibrioception(GO:0050957) |
0.3 | 1.5 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.3 | 0.9 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.3 | 0.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.3 | 0.3 | GO:0048144 | fibroblast proliferation(GO:0048144) regulation of fibroblast proliferation(GO:0048145) |
0.3 | 1.8 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.3 | 0.9 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.3 | 2.4 | GO:0032456 | endocytic recycling(GO:0032456) |
0.3 | 1.2 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.3 | 3.3 | GO:0035329 | hippo signaling(GO:0035329) |
0.3 | 2.4 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.3 | 0.9 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.3 | 1.2 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.3 | 0.6 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.3 | 2.7 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
0.3 | 0.6 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.3 | 1.2 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.3 | 2.4 | GO:0045730 | respiratory burst(GO:0045730) |
0.3 | 0.3 | GO:0071503 | response to heparin(GO:0071503) |
0.3 | 3.8 | GO:0006400 | tRNA modification(GO:0006400) |
0.3 | 3.5 | GO:1990266 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
0.3 | 5.9 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.3 | 0.6 | GO:0070340 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.3 | 3.8 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.3 | 1.5 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.3 | 1.8 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.3 | 2.1 | GO:0001881 | receptor recycling(GO:0001881) |
0.3 | 0.9 | GO:0045765 | regulation of angiogenesis(GO:0045765) |
0.3 | 1.2 | GO:0007566 | embryo implantation(GO:0007566) |
0.3 | 1.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.3 | 0.6 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
0.3 | 0.9 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.3 | 0.3 | GO:0034969 | histone arginine methylation(GO:0034969) histone H4-R3 methylation(GO:0043985) |
0.3 | 1.7 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.3 | 3.2 | GO:0001709 | cell fate determination(GO:0001709) |
0.3 | 1.4 | GO:0007584 | response to nutrient(GO:0007584) |
0.3 | 2.0 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.3 | 0.3 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.3 | 0.3 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.3 | 1.1 | GO:0051383 | kinetochore organization(GO:0051383) |
0.3 | 2.9 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.3 | 1.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.3 | 1.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.3 | 1.1 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.3 | 0.6 | GO:0048645 | organ formation(GO:0048645) |
0.3 | 0.6 | GO:0045786 | negative regulation of cell cycle(GO:0045786) |
0.3 | 0.6 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.3 | 1.1 | GO:0032200 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.3 | 2.5 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.3 | 1.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.3 | 0.3 | GO:0010922 | positive regulation of phosphatase activity(GO:0010922) positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.3 | 0.6 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.3 | 0.3 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.3 | 0.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.3 | 0.8 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.3 | 0.6 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.3 | 0.3 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.3 | 0.8 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.3 | 0.8 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.3 | 14.3 | GO:0008033 | tRNA processing(GO:0008033) |
0.3 | 0.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.3 | 1.4 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.3 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.3 | 1.4 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.3 | 0.8 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.3 | 2.7 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.3 | 1.1 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.3 | 0.5 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.3 | 0.3 | GO:0007346 | regulation of mitotic cell cycle(GO:0007346) |
0.3 | 0.3 | GO:0060119 | inner ear receptor cell development(GO:0060119) |
0.3 | 2.7 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.3 | 0.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.3 | 1.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.3 | 2.1 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.3 | 9.9 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.3 | 5.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.3 | 0.3 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.3 | 0.5 | GO:0060413 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.3 | 1.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.3 | 0.8 | GO:0009650 | UV protection(GO:0009650) |
0.3 | 2.6 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.3 | 0.5 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.3 | 1.0 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.3 | 0.8 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.3 | 0.8 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.3 | 3.6 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.3 | 0.3 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.3 | 0.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.3 | 7.5 | GO:0040008 | regulation of growth(GO:0040008) |
0.3 | 0.5 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.3 | 2.1 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.3 | 0.8 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.3 | 0.3 | GO:0034143 | regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
0.3 | 2.3 | GO:0016925 | protein sumoylation(GO:0016925) |
0.3 | 0.5 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.3 | 2.3 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.3 | 1.0 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.3 | 0.3 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.3 | 2.3 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.3 | 1.3 | GO:0030033 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.3 | 2.8 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.3 | 1.0 | GO:0048017 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.3 | 0.5 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.3 | 1.3 | GO:0072595 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) protein localization to endoplasmic reticulum(GO:0070972) maintenance of protein localization in organelle(GO:0072595) |
0.3 | 2.0 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.3 | 11.0 | GO:0006413 | translational initiation(GO:0006413) |
0.3 | 0.5 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.3 | 0.8 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 1.0 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.2 | 0.5 | GO:0021675 | nerve development(GO:0021675) |
0.2 | 0.2 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.2 | 1.5 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.2 | 0.2 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.2 | 0.5 | GO:0001878 | response to yeast(GO:0001878) |
0.2 | 0.7 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.2 | 0.2 | GO:0032970 | regulation of actin filament-based process(GO:0032970) |
0.2 | 0.5 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 0.7 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 1.7 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.2 | 1.0 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.2 | 13.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 0.5 | GO:0045844 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.2 | 1.7 | GO:0006415 | translational termination(GO:0006415) |
0.2 | 0.7 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 0.7 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.2 | 2.2 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.2 | 0.5 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.2 | 0.5 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.2 | 3.4 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.2 | 1.7 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.2 | 0.7 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.2 | 0.7 | GO:0070295 | renal water absorption(GO:0070295) |
0.2 | 0.5 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.2 | 1.2 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.2 | 1.0 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.2 | 1.4 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 5.5 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.2 | 0.7 | GO:2000178 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.2 | 0.5 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.2 | 0.5 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.2 | 1.9 | GO:0010039 | response to iron ion(GO:0010039) |
0.2 | 0.2 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.2 | 0.2 | GO:0097576 | vacuole fusion(GO:0097576) |
0.2 | 0.7 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.2 | 0.2 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.2 | 2.1 | GO:0045762 | positive regulation of adenylate cyclase activity(GO:0045762) |
0.2 | 1.4 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.2 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.2 | 1.9 | GO:0001754 | eye photoreceptor cell differentiation(GO:0001754) eye photoreceptor cell development(GO:0042462) |
0.2 | 1.2 | GO:0032273 | positive regulation of protein polymerization(GO:0032273) |
0.2 | 2.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 0.7 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.2 | 0.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 5.3 | GO:0007041 | lysosomal transport(GO:0007041) |
0.2 | 0.5 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 4.4 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.2 | 0.7 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.2 | 0.7 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.2 | 3.9 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 1.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.2 | 0.7 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.2 | 0.5 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.2 | 1.1 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
0.2 | 3.4 | GO:0043487 | regulation of RNA stability(GO:0043487) |
0.2 | 4.5 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.2 | 0.7 | GO:0001570 | vasculogenesis(GO:0001570) |
0.2 | 0.7 | GO:0044070 | regulation of anion transport(GO:0044070) |
0.2 | 1.4 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.2 | 4.5 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.2 | 0.9 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.2 | 0.5 | GO:0042640 | anagen(GO:0042640) |
0.2 | 0.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 0.2 | GO:0043137 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.2 | 0.9 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 1.6 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.2 | 0.9 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.2 | 9.0 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.2 | 2.0 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.2 | 1.8 | GO:0051324 | prophase(GO:0051324) |
0.2 | 1.6 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.2 | 0.7 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.2 | 2.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 1.3 | GO:0009100 | glycoprotein metabolic process(GO:0009100) |
0.2 | 1.3 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.2 | 0.7 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.2 | 0.4 | GO:0035269 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.2 | 1.1 | GO:0030323 | respiratory tube development(GO:0030323) |
0.2 | 0.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 0.2 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.2 | 0.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.4 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 0.6 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.2 | 2.4 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.2 | 0.6 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.2 | 0.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 1.9 | GO:0006974 | cellular response to DNA damage stimulus(GO:0006974) |
0.2 | 0.2 | GO:0021548 | pons development(GO:0021548) |
0.2 | 1.1 | GO:0034311 | diol metabolic process(GO:0034311) |
0.2 | 1.1 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.2 | 0.2 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.2 | 0.2 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.2 | 0.2 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.2 | 1.7 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.2 | 1.7 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.2 | 1.7 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.2 | 1.5 | GO:0031100 | organ regeneration(GO:0031100) |
0.2 | 0.4 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.2 | 0.6 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.2 | 0.4 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 21.9 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.2 | 0.4 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.2 | 0.8 | GO:0030326 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
0.2 | 0.6 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.2 | 0.4 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.2 | 0.8 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.2 | 0.6 | GO:0048753 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
0.2 | 0.8 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.2 | 0.8 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 1.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.8 | GO:0043269 | regulation of ion transport(GO:0043269) |
0.2 | 1.9 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.2 | 3.9 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.2 | 0.4 | GO:0033045 | regulation of sister chromatid segregation(GO:0033045) |
0.2 | 2.0 | GO:0007162 | negative regulation of cell adhesion(GO:0007162) |
0.2 | 4.3 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 0.6 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.2 | 6.7 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.2 | 0.6 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.2 | 0.6 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.2 | 1.4 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.2 | 0.2 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.2 | 3.3 | GO:0007498 | mesoderm development(GO:0007498) |
0.2 | 0.2 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.2 | 0.4 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.2 | 2.4 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.2 | 0.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 6.3 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.2 | 4.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.2 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 0.8 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.2 | 0.2 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.2 | 0.4 | GO:0002883 | hypersensitivity(GO:0002524) regulation of acute inflammatory response to antigenic stimulus(GO:0002864) positive regulation of acute inflammatory response to antigenic stimulus(GO:0002866) regulation of hypersensitivity(GO:0002883) positive regulation of hypersensitivity(GO:0002885) |
0.2 | 0.8 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 0.6 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.2 | 0.6 | GO:0009799 | specification of symmetry(GO:0009799) |
0.2 | 3.4 | GO:1903051 | negative regulation of proteolysis involved in cellular protein catabolic process(GO:1903051) |
0.2 | 1.6 | GO:0009060 | aerobic respiration(GO:0009060) |
0.2 | 1.0 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.2 | 0.8 | GO:0042102 | positive regulation of T cell proliferation(GO:0042102) |
0.2 | 1.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 3.2 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.2 | 0.4 | GO:0016246 | RNA interference(GO:0016246) |
0.2 | 3.1 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 1.2 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.2 | 0.4 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 0.4 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.2 | 0.8 | GO:0051904 | establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) pigment granule transport(GO:0051904) establishment of pigment granule localization(GO:0051905) |
0.2 | 1.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.4 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.2 | 0.4 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.2 | 0.4 | GO:0061136 | regulation of proteasomal protein catabolic process(GO:0061136) |
0.2 | 4.1 | GO:0019079 | viral genome replication(GO:0019079) |
0.2 | 1.2 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
0.2 | 0.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 0.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 1.5 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.2 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 0.6 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
0.2 | 1.2 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 0.2 | GO:0032623 | interleukin-2 production(GO:0032623) |
0.2 | 0.2 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.2 | 1.3 | GO:0016049 | cell growth(GO:0016049) |
0.2 | 0.4 | GO:0031638 | zymogen activation(GO:0031638) |
0.2 | 0.4 | GO:0032376 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.2 | 0.4 | GO:0007625 | grooming behavior(GO:0007625) |
0.2 | 1.5 | GO:0001893 | maternal placenta development(GO:0001893) |
0.2 | 1.7 | GO:0007340 | acrosome reaction(GO:0007340) |
0.2 | 0.6 | GO:0071569 | protein ufmylation(GO:0071569) |
0.2 | 0.9 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 0.4 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) regulation of membrane lipid distribution(GO:0097035) |
0.2 | 0.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 7.7 | GO:0010952 | positive regulation of peptidase activity(GO:0010952) |
0.2 | 1.1 | GO:0007379 | segment specification(GO:0007379) |
0.2 | 0.2 | GO:0048821 | erythrocyte development(GO:0048821) myeloid cell development(GO:0061515) |
0.2 | 1.9 | GO:0001947 | heart looping(GO:0001947) embryonic heart tube morphogenesis(GO:0003143) determination of heart left/right asymmetry(GO:0061371) |
0.2 | 0.4 | GO:0071027 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.2 | 1.7 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 3.2 | GO:0043486 | histone exchange(GO:0043486) |
0.2 | 2.6 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.2 | 13.2 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.2 | 0.6 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.2 | 2.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.2 | 0.6 | GO:0014070 | response to organic cyclic compound(GO:0014070) |
0.2 | 0.4 | GO:0009219 | pyrimidine deoxyribonucleotide metabolic process(GO:0009219) |
0.2 | 0.9 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.2 | 4.2 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
0.2 | 1.3 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.2 | 0.2 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.2 | 2.9 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.2 | 2.4 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.2 | 0.2 | GO:0002823 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.2 | 3.4 | GO:0051402 | neuron apoptotic process(GO:0051402) |
0.2 | 0.7 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.2 | 0.5 | GO:0042559 | tetrahydrobiopterin biosynthetic process(GO:0006729) pteridine-containing compound biosynthetic process(GO:0042559) tetrahydrobiopterin metabolic process(GO:0046146) |
0.2 | 0.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 2.0 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
0.2 | 2.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 0.2 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.2 | 4.0 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.2 | 1.8 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.2 | 0.9 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.2 | 6.8 | GO:0071772 | BMP signaling pathway(GO:0030509) response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.2 | 0.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 0.2 | GO:0032760 | positive regulation of tumor necrosis factor production(GO:0032760) |
0.2 | 21.4 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.2 | 0.2 | GO:0060393 | pathway-restricted SMAD protein phosphorylation(GO:0060389) regulation of pathway-restricted SMAD protein phosphorylation(GO:0060393) |
0.2 | 3.0 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.2 | 0.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.4 | GO:1903039 | positive regulation of T cell activation(GO:0050870) positive regulation of leukocyte cell-cell adhesion(GO:1903039) |
0.2 | 0.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.2 | 0.4 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.2 | 0.4 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.2 | 1.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 1.8 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.2 | 1.6 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.2 | 0.2 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.2 | 0.9 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.2 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 7.9 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) cell cycle G2/M phase transition(GO:0044839) |
0.2 | 5.9 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.2 | 0.5 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.7 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.2 | 1.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 0.9 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.2 | 3.1 | GO:0016571 | histone methylation(GO:0016571) |
0.2 | 6.3 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.2 | 1.2 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.2 | 0.7 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.2 | 0.5 | GO:0022618 | ribonucleoprotein complex assembly(GO:0022618) |
0.2 | 17.5 | GO:0022900 | electron transport chain(GO:0022900) |
0.2 | 5.7 | GO:0006090 | pyruvate metabolic process(GO:0006090) |
0.2 | 2.7 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.2 | 0.8 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 0.2 | GO:0030431 | sleep(GO:0030431) |
0.2 | 0.2 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.2 | 0.7 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.2 | 4.5 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.2 | 0.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 0.5 | GO:0009414 | response to water deprivation(GO:0009414) |
0.2 | 1.3 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.2 | 0.3 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.2 | 0.7 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 0.7 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.2 | 1.3 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 1.3 | GO:0051789 | obsolete response to protein(GO:0051789) |
0.2 | 2.0 | GO:0031929 | TOR signaling(GO:0031929) |
0.2 | 1.3 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.2 | 0.2 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.2 | 0.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 0.2 | GO:1902667 | regulation of axon guidance(GO:1902667) |
0.2 | 0.5 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.2 | 3.7 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.2 | 0.2 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.2 | 18.6 | GO:0016032 | viral process(GO:0016032) |
0.2 | 0.6 | GO:0050679 | positive regulation of epithelial cell proliferation(GO:0050679) |
0.2 | 1.4 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.2 | 2.1 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.2 | 1.4 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.2 | 0.2 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.2 | 1.6 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.2 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 0.2 | GO:0001841 | neural tube formation(GO:0001841) |
0.2 | 11.5 | GO:0006414 | translational elongation(GO:0006414) |
0.2 | 0.5 | GO:0009408 | response to heat(GO:0009408) |
0.2 | 0.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 0.5 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.2 | 0.5 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.2 | 0.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 0.6 | GO:0007549 | dosage compensation(GO:0007549) |
0.2 | 0.3 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
0.2 | 0.9 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 2.3 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.3 | GO:0055069 | cellular zinc ion homeostasis(GO:0006882) zinc ion homeostasis(GO:0055069) |
0.2 | 1.4 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
0.2 | 1.2 | GO:0051923 | sulfation(GO:0051923) |
0.2 | 0.2 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.2 | 2.5 | GO:0033762 | response to glucagon(GO:0033762) cellular response to glucagon stimulus(GO:0071377) |
0.2 | 2.2 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.2 | 0.8 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 0.8 | GO:1903321 | negative regulation of protein ubiquitination(GO:0031397) negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.2 | 0.5 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.2 | 0.2 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.2 | 0.2 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.2 | 0.5 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.2 | 0.6 | GO:0016311 | dephosphorylation(GO:0016311) |
0.2 | 0.9 | GO:0000279 | M phase(GO:0000279) |
0.2 | 0.8 | GO:0009304 | tRNA transcription(GO:0009304) 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.2 | 0.2 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
0.2 | 3.8 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.2 | 0.3 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 0.3 | GO:0045007 | depurination(GO:0045007) |
0.1 | 0.3 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 5.2 | GO:0006914 | autophagy(GO:0006914) |
0.1 | 0.1 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.1 | 1.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.1 | GO:0033574 | response to testosterone(GO:0033574) |
0.1 | 0.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.3 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.4 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.1 | 0.7 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 1.0 | GO:0030099 | myeloid cell differentiation(GO:0030099) |
0.1 | 1.4 | GO:0019915 | lipid storage(GO:0019915) |
0.1 | 1.7 | GO:0051302 | regulation of cell division(GO:0051302) |
0.1 | 17.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 6.2 | GO:0016568 | chromatin modification(GO:0016568) |
0.1 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 1.7 | GO:1904018 | positive regulation of vasculature development(GO:1904018) |
0.1 | 21.2 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 0.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 12.2 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.4 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.3 | GO:0001660 | fever generation(GO:0001660) |
0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.4 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.1 | 0.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.1 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.1 | 0.1 | GO:0097306 | cellular response to alcohol(GO:0097306) |
0.1 | 0.3 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.3 | GO:0034644 | cellular response to UV(GO:0034644) |
0.1 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.4 | GO:0006833 | water transport(GO:0006833) fluid transport(GO:0042044) |
0.1 | 8.7 | GO:0034728 | nucleosome organization(GO:0034728) |
0.1 | 3.2 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.1 | 0.4 | GO:0071715 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
0.1 | 1.4 | GO:0001952 | regulation of cell-matrix adhesion(GO:0001952) |
0.1 | 0.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 1.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 0.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.3 | GO:0031497 | chromatin assembly(GO:0031497) |
0.1 | 4.3 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
0.1 | 3.0 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 1.1 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 2.0 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.1 | 0.3 | GO:0007613 | memory(GO:0007613) |
0.1 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 4.8 | GO:0007623 | circadian rhythm(GO:0007623) |
0.1 | 0.7 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 11.0 | GO:0006486 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) glycosylation(GO:0070085) |
0.1 | 0.1 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 1.0 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 13.6 | GO:0006511 | ubiquitin-dependent protein catabolic process(GO:0006511) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 1.3 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 19.8 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.1 | 1.3 | GO:0005977 | glycogen metabolic process(GO:0005977) |
0.1 | 1.0 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.1 | 0.1 | GO:0036230 | granulocyte activation(GO:0036230) |
0.1 | 0.1 | GO:0045768 | obsolete positive regulation of anti-apoptosis(GO:0045768) |
0.1 | 0.1 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.1 | 2.4 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 4.2 | GO:0007034 | vacuolar transport(GO:0007034) |
0.1 | 0.4 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.1 | 0.4 | GO:0019627 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) nitrogen cycle metabolic process(GO:0071941) |
0.1 | 1.1 | GO:0006091 | generation of precursor metabolites and energy(GO:0006091) |
0.1 | 1.6 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.1 | 0.4 | GO:0046039 | pyrimidine nucleoside triphosphate metabolic process(GO:0009147) GTP metabolic process(GO:0046039) |
0.1 | 1.9 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.1 | 0.7 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.6 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 3.3 | GO:0002576 | platelet degranulation(GO:0002576) |
0.1 | 4.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 10.0 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.1 | 1.8 | GO:0030097 | hemopoiesis(GO:0030097) |
0.1 | 3.5 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.1 | 4.6 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.1 | 1.3 | GO:0007422 | peripheral nervous system development(GO:0007422) |
0.1 | 0.5 | GO:0006023 | aminoglycan biosynthetic process(GO:0006023) |
0.1 | 0.2 | GO:1901292 | nucleoside phosphate catabolic process(GO:1901292) |
0.1 | 0.2 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 0.1 | GO:0060840 | artery development(GO:0060840) |
0.1 | 2.4 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.1 | 0.2 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.1 | 4.3 | GO:0016051 | carbohydrate biosynthetic process(GO:0016051) |
0.1 | 2.7 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.2 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.5 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.1 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.2 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.2 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 6.0 | GO:0030168 | platelet activation(GO:0030168) |
0.1 | 0.2 | GO:0010976 | positive regulation of neuron projection development(GO:0010976) |
0.1 | 0.3 | GO:0044848 | biological phase(GO:0044848) |
0.1 | 0.7 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 0.1 | GO:0045684 | positive regulation of epidermis development(GO:0045684) |
0.1 | 3.0 | GO:0006302 | double-strand break repair(GO:0006302) |
0.1 | 0.5 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 1.6 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.1 | 0.9 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.1 | 4.8 | GO:0098609 | cell-cell adhesion(GO:0098609) |
0.1 | 0.3 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.7 | GO:0031668 | cellular response to extracellular stimulus(GO:0031668) |
0.1 | 0.2 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 1.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.5 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.1 | 0.4 | GO:0061008 | hepaticobiliary system development(GO:0061008) |
0.1 | 0.3 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.1 | 0.7 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.1 | 1.1 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
0.1 | 3.9 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.1 | 0.1 | GO:0015853 | adenine transport(GO:0015853) |
0.1 | 0.5 | GO:0016485 | protein processing(GO:0016485) |
0.1 | 0.6 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.1 | 0.1 | GO:0090311 | regulation of protein deacetylation(GO:0090311) positive regulation of protein deacetylation(GO:0090312) |
0.1 | 0.9 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.1 | 0.2 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 0.2 | GO:0021915 | neural tube development(GO:0021915) |
0.1 | 0.1 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.1 | 2.3 | GO:0015682 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.1 | 0.1 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.1 | 1.4 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.1 | 0.7 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.1 | 0.4 | GO:0006200 | obsolete ATP catabolic process(GO:0006200) |
0.1 | 1.6 | GO:0001666 | response to hypoxia(GO:0001666) |
0.1 | 0.3 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 2.0 | GO:0032872 | regulation of stress-activated MAPK cascade(GO:0032872) |
0.1 | 1.1 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.1 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.1 | 0.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 0.1 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.1 | 0.5 | GO:0010467 | gene expression(GO:0010467) |
0.1 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.3 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 7.8 | GO:0006281 | DNA repair(GO:0006281) |
0.1 | 2.6 | GO:0061025 | membrane fusion(GO:0061025) |
0.1 | 0.1 | GO:0008306 | associative learning(GO:0008306) |
0.1 | 5.0 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.1 | 0.9 | GO:0007015 | actin filament organization(GO:0007015) |
0.1 | 0.5 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.5 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 1.1 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.1 | 0.1 | GO:0021543 | pallium development(GO:0021543) |
0.1 | 1.1 | GO:0032496 | response to lipopolysaccharide(GO:0032496) |
0.1 | 0.6 | GO:0050663 | cytokine secretion(GO:0050663) |
0.1 | 0.1 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 1.9 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.1 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.1 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.1 | 0.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.7 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 0.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.4 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.1 | 0.6 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 0.4 | GO:0010629 | negative regulation of gene expression(GO:0010629) |
0.1 | 0.7 | GO:0006325 | chromatin organization(GO:0006325) |
0.1 | 0.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.2 | GO:0035051 | cardiocyte differentiation(GO:0035051) |
0.1 | 0.1 | GO:0044241 | lipid digestion(GO:0044241) |
0.1 | 0.5 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.7 | GO:0043010 | camera-type eye development(GO:0043010) |
0.1 | 0.1 | GO:0017085 | response to insecticide(GO:0017085) |
0.1 | 0.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.1 | GO:0048305 | immunoglobulin secretion(GO:0048305) regulation of immunoglobulin secretion(GO:0051023) |
0.1 | 3.7 | GO:0010876 | lipid localization(GO:0010876) |
0.1 | 1.1 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 5.5 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.8 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.6 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.3 | GO:0051297 | centrosome organization(GO:0051297) |
0.1 | 0.2 | GO:0009416 | response to light stimulus(GO:0009416) |
0.1 | 1.1 | GO:0042493 | response to drug(GO:0042493) |
0.1 | 0.1 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 1.1 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.1 | 0.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.6 | GO:0019674 | NAD metabolic process(GO:0019674) |
0.1 | 0.2 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.1 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 5.0 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.1 | 0.2 | GO:0048515 | spermatid differentiation(GO:0048515) |
0.1 | 0.1 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.1 | 0.2 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.1 | 0.9 | GO:0097696 | JAK-STAT cascade(GO:0007259) STAT cascade(GO:0097696) |
0.1 | 0.2 | GO:0001832 | blastocyst growth(GO:0001832) |
0.1 | 0.1 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.3 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.1 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 2.6 | GO:0034470 | ncRNA processing(GO:0034470) |
0.1 | 0.4 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.1 | 0.3 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.1 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.1 | 6.2 | GO:0006644 | phospholipid metabolic process(GO:0006644) |
0.1 | 0.1 | GO:0015810 | C4-dicarboxylate transport(GO:0015740) aspartate transport(GO:0015810) |
0.1 | 2.8 | GO:0051169 | nuclear transport(GO:0051169) |
0.1 | 0.2 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.6 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.1 | 0.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.2 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.2 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.9 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.1 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.1 | 0.5 | GO:0045333 | cellular respiration(GO:0045333) |
0.1 | 0.1 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.1 | 0.1 | GO:0050773 | regulation of dendrite development(GO:0050773) |
0.1 | 0.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.1 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 1.2 | GO:0006826 | iron ion transport(GO:0006826) |
0.1 | 4.1 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.1 | 1.2 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 0.1 | GO:0044042 | cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.1 | 1.3 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.2 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 1.2 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.1 | 0.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.1 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.2 | GO:1990138 | axon extension(GO:0048675) neuron projection extension(GO:1990138) |
0.1 | 0.1 | GO:0043254 | regulation of protein complex assembly(GO:0043254) |
0.1 | 0.1 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.1 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.1 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.2 | GO:0006304 | DNA modification(GO:0006304) |
0.1 | 3.0 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.1 | 0.1 | GO:0009069 | serine family amino acid metabolic process(GO:0009069) |
0.1 | 71.6 | GO:0034645 | cellular macromolecule biosynthetic process(GO:0034645) |
0.1 | 0.4 | GO:1901998 | antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.1 | 0.1 | GO:0046434 | organophosphate catabolic process(GO:0046434) |
0.1 | 0.2 | GO:0045927 | positive regulation of growth(GO:0045927) |
0.1 | 0.9 | GO:0071774 | fibroblast growth factor receptor signaling pathway(GO:0008543) cellular response to fibroblast growth factor stimulus(GO:0044344) response to fibroblast growth factor(GO:0071774) |
0.1 | 0.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.1 | GO:0007031 | peroxisome organization(GO:0007031) |
0.1 | 0.3 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 4.7 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.1 | 1.4 | GO:0006396 | RNA processing(GO:0006396) |
0.1 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.8 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.1 | 0.2 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.1 | 0.2 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.3 | GO:0030801 | positive regulation of cyclic nucleotide metabolic process(GO:0030801) |
0.1 | 0.2 | GO:0016358 | dendrite development(GO:0016358) |
0.1 | 0.4 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 16.5 | GO:0015031 | protein transport(GO:0015031) |
0.1 | 0.2 | GO:0042180 | cellular ketone metabolic process(GO:0042180) |
0.1 | 0.1 | GO:0034599 | cellular response to oxidative stress(GO:0034599) |
0.1 | 0.7 | GO:0016070 | RNA metabolic process(GO:0016070) |
0.1 | 1.1 | GO:0007338 | single fertilization(GO:0007338) |
0.1 | 0.1 | GO:0044764 | multi-organism cellular process(GO:0044764) |
0.1 | 0.1 | GO:0061383 | trabecula formation(GO:0060343) trabecula morphogenesis(GO:0061383) |
0.1 | 0.2 | GO:0002218 | activation of innate immune response(GO:0002218) |
0.1 | 0.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.5 | GO:0001906 | cell killing(GO:0001906) |
0.0 | 0.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.0 | 0.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.0 | GO:0032770 | positive regulation of monooxygenase activity(GO:0032770) |
0.0 | 0.0 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.0 | GO:0030031 | cell projection assembly(GO:0030031) |
0.0 | 0.1 | GO:0007416 | synapse assembly(GO:0007416) |
0.0 | 0.1 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.0 | 13.7 | GO:0006508 | proteolysis(GO:0006508) |
0.0 | 2.6 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
0.0 | 0.0 | GO:0021766 | hippocampus development(GO:0021766) |
0.0 | 0.0 | GO:0007369 | gastrulation(GO:0007369) |
0.0 | 0.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.0 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.1 | GO:0090150 | establishment of protein localization to membrane(GO:0090150) |
0.0 | 0.6 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.1 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.0 | 0.0 | GO:0033673 | negative regulation of kinase activity(GO:0033673) |
0.0 | 0.6 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.0 | 0.0 | GO:0055076 | transition metal ion homeostasis(GO:0055076) |
0.0 | 0.7 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.2 | GO:0008344 | adult locomotory behavior(GO:0008344) |
0.0 | 0.4 | GO:0010243 | response to organonitrogen compound(GO:0010243) |
0.0 | 0.0 | GO:0002507 | tolerance induction(GO:0002507) |
0.0 | 0.1 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.2 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 5.3 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.0 | 0.7 | GO:0009161 | ribonucleoside monophosphate metabolic process(GO:0009161) |
0.0 | 0.1 | GO:0051726 | regulation of cell cycle(GO:0051726) |
0.0 | 0.4 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.0 | 0.0 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.3 | GO:0002526 | acute inflammatory response(GO:0002526) |
0.0 | 0.0 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.0 | 0.0 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.2 | GO:0009628 | response to abiotic stimulus(GO:0009628) |
0.0 | 0.6 | GO:0030048 | actin filament-based movement(GO:0030048) |
0.0 | 0.0 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.0 | 1.0 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.0 | 0.1 | GO:0043473 | pigmentation(GO:0043473) |
0.0 | 0.0 | GO:0034504 | protein localization to nucleus(GO:0034504) |
0.0 | 6.5 | GO:0007155 | cell adhesion(GO:0007155) |
0.0 | 0.1 | GO:0051181 | cofactor transport(GO:0051181) |
0.0 | 0.0 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.0 | 0.5 | GO:0007565 | female pregnancy(GO:0007565) |
0.0 | 0.0 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.0 | 0.0 | GO:0043271 | negative regulation of ion transport(GO:0043271) |
0.0 | 0.2 | GO:0030278 | regulation of ossification(GO:0030278) |
0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 1.5 | GO:0034220 | ion transmembrane transport(GO:0034220) |
0.0 | 4.4 | GO:0008219 | cell death(GO:0008219) |
0.0 | 0.0 | GO:0052646 | glycerol-3-phosphate metabolic process(GO:0006072) alditol phosphate metabolic process(GO:0052646) |
0.0 | 0.3 | GO:0000280 | nuclear division(GO:0000280) |
0.0 | 0.0 | GO:0032787 | monocarboxylic acid metabolic process(GO:0032787) |
0.0 | 0.0 | GO:0031349 | positive regulation of defense response(GO:0031349) |
0.0 | 0.5 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.0 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.0 | 0.0 | GO:0070509 | calcium ion import(GO:0070509) |
0.0 | 0.1 | GO:0000041 | transition metal ion transport(GO:0000041) |
0.0 | 0.0 | GO:0002764 | immune response-regulating signaling pathway(GO:0002764) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.1 | 4.4 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
1.0 | 3.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.0 | 4.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.9 | 0.9 | GO:0000407 | pre-autophagosomal structure(GO:0000407) pre-autophagosomal structure membrane(GO:0034045) |
0.9 | 0.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.8 | 16.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.8 | 2.3 | GO:0072487 | MSL complex(GO:0072487) |
0.7 | 3.7 | GO:0071437 | invadopodium(GO:0071437) |
0.7 | 2.9 | GO:0005915 | zonula adherens(GO:0005915) |
0.7 | 2.2 | GO:0031932 | TORC2 complex(GO:0031932) |
0.7 | 3.4 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.7 | 2.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.7 | 2.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.6 | 2.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.6 | 0.6 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.6 | 0.6 | GO:0030425 | dendrite(GO:0030425) |
0.6 | 6.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.6 | 0.6 | GO:0000785 | chromatin(GO:0000785) |
0.6 | 1.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.6 | 7.2 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.6 | 4.1 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.6 | 2.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.6 | 1.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.6 | 1.7 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.5 | 0.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.5 | 1.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.5 | 10.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.5 | 3.5 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.5 | 4.0 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.5 | 4.0 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.5 | 2.0 | GO:0030914 | STAGA complex(GO:0030914) |
0.5 | 2.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.5 | 1.9 | GO:0032059 | bleb(GO:0032059) |
0.5 | 6.3 | GO:0043209 | myelin sheath(GO:0043209) |
0.5 | 1.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.5 | 4.3 | GO:0001726 | ruffle(GO:0001726) |
0.5 | 4.3 | GO:0042555 | MCM complex(GO:0042555) |
0.5 | 2.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 4.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.5 | 5.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.5 | 0.9 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.5 | 3.7 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.4 | 1.3 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.4 | 2.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 1.8 | GO:0044304 | main axon(GO:0044304) |
0.4 | 2.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.4 | 1.7 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.4 | 10.8 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.4 | 7.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.4 | 1.3 | GO:0032009 | early phagosome(GO:0032009) |
0.4 | 1.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.4 | 1.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.4 | 4.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.4 | 1.6 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.4 | 1.6 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.4 | 1.2 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.4 | 2.8 | GO:0043025 | neuronal cell body(GO:0043025) |
0.4 | 3.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.4 | 2.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.4 | 3.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 6.7 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.4 | 3.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.4 | 5.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.4 | 1.5 | GO:0005827 | polar microtubule(GO:0005827) |
0.4 | 0.4 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 2.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.4 | 22.8 | GO:0030426 | growth cone(GO:0030426) |
0.4 | 1.9 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.4 | 1.1 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.4 | 3.0 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.4 | 2.6 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.4 | 0.7 | GO:0070852 | cell body fiber(GO:0070852) |
0.4 | 3.2 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.4 | 4.3 | GO:0032039 | integrator complex(GO:0032039) |
0.4 | 4.3 | GO:0071565 | nBAF complex(GO:0071565) |
0.4 | 1.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.4 | 1.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.4 | 3.2 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.4 | 31.7 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.4 | 12.8 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.4 | 7.0 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 1.0 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.3 | 2.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 3.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 4.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.3 | 2.7 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.3 | 1.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.3 | 1.7 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.3 | 1.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 1.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 4.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 3.6 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 1.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.3 | 2.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.3 | 12.8 | GO:0036064 | ciliary basal body(GO:0036064) |
0.3 | 27.0 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.3 | 19.3 | GO:0030027 | lamellipodium(GO:0030027) |
0.3 | 1.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 2.5 | GO:0005861 | troponin complex(GO:0005861) |
0.3 | 4.4 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.3 | 2.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 12.1 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.3 | 0.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 1.8 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.3 | 1.2 | GO:0005844 | polysome(GO:0005844) |
0.3 | 13.9 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.3 | 2.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 1.2 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.3 | 3.9 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.3 | 1.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.3 | 0.3 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.3 | 16.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.3 | 4.4 | GO:0005811 | lipid particle(GO:0005811) |
0.3 | 1.2 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.3 | 7.3 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.3 | 1.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 1.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.3 | 1.7 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.3 | 1.4 | GO:0030870 | Mre11 complex(GO:0030870) |
0.3 | 1.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.3 | 2.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 1.4 | GO:0002102 | podosome(GO:0002102) |
0.3 | 1.4 | GO:0099738 | apical cortex(GO:0045179) cell cortex region(GO:0099738) |
0.3 | 1.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 7.8 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.3 | 1.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.3 | 1.4 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 2.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 1.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 2.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 3.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.3 | 1.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.3 | 0.3 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.3 | 0.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 1.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 14.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.3 | 0.5 | GO:0042588 | zymogen granule(GO:0042588) |
0.3 | 0.3 | GO:0031674 | I band(GO:0031674) |
0.3 | 1.8 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.3 | 1.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.3 | 1.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 14.5 | GO:0031902 | late endosome membrane(GO:0031902) |
0.3 | 2.4 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.3 | 5.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 6.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 0.8 | GO:0012506 | vesicle membrane(GO:0012506) |
0.3 | 0.5 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.3 | 2.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 5.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.3 | 10.9 | GO:0005813 | centrosome(GO:0005813) |
0.3 | 0.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 0.7 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.2 | 0.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 5.9 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 1.5 | GO:0031430 | M band(GO:0031430) |
0.2 | 1.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 1.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 1.7 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 0.7 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 2.6 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 5.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 7.9 | GO:0031256 | leading edge membrane(GO:0031256) |
0.2 | 25.6 | GO:0005769 | early endosome(GO:0005769) |
0.2 | 3.6 | GO:0035097 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.2 | 2.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 52.0 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 1.2 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 4.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 0.7 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 21.9 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.2 | 0.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.2 | 1.4 | GO:0000776 | kinetochore(GO:0000776) |
0.2 | 13.0 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.2 | 0.7 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 1.4 | GO:0005657 | replication fork(GO:0005657) |
0.2 | 6.4 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 3.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 1.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 0.5 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 2.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 0.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 2.9 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.2 | 1.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 6.2 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 0.7 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.2 | 6.4 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 5.7 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.2 | 0.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.2 | 1.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 3.5 | GO:0030018 | Z disc(GO:0030018) |
0.2 | 1.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 2.8 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 1.5 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 1.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.2 | 1.1 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.2 | 10.0 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
0.2 | 1.1 | GO:0031095 | platelet dense tubular network(GO:0031094) platelet dense tubular network membrane(GO:0031095) |
0.2 | 4.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 0.4 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 4.6 | GO:0030496 | midbody(GO:0030496) |
0.2 | 1.0 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.2 | 0.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 4.6 | GO:0005680 | nuclear ubiquitin ligase complex(GO:0000152) anaphase-promoting complex(GO:0005680) |
0.2 | 13.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 0.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 3.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 0.8 | GO:0001740 | Barr body(GO:0001740) |
0.2 | 0.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 1.9 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 1.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 0.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 1.2 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 0.4 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.2 | 0.8 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 69.5 | GO:0000139 | Golgi membrane(GO:0000139) |
0.2 | 3.4 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 3.8 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 0.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 1.0 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 15.0 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 18.6 | GO:0016607 | nuclear speck(GO:0016607) |
0.2 | 1.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.2 | 4.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 7.0 | GO:0005819 | spindle(GO:0005819) |
0.2 | 2.4 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 1.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 12.1 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.2 | 93.8 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 2.0 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 1.1 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.2 | 4.6 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.2 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 3.4 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.2 | 599.9 | GO:0005634 | nucleus(GO:0005634) |
0.2 | 1.1 | GO:0012505 | endomembrane system(GO:0012505) |
0.2 | 29.3 | GO:0070013 | intracellular organelle lumen(GO:0070013) |
0.2 | 0.3 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.2 | 107.7 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 6.0 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.2 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 23.4 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.2 | 16.7 | GO:0005874 | microtubule(GO:0005874) |
0.2 | 7.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 0.6 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.2 | 4.1 | GO:0031974 | membrane-enclosed lumen(GO:0031974) |
0.1 | 0.4 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 2.1 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.1 | 4.8 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.1 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 84.6 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 6.9 | GO:0005768 | endosome(GO:0005768) |
0.1 | 0.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 55.9 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.4 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 5.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.5 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 5.1 | GO:0030424 | axon(GO:0030424) |
0.1 | 0.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.4 | GO:0031252 | cell leading edge(GO:0031252) |
0.1 | 1.0 | GO:0030017 | sarcomere(GO:0030017) |
0.1 | 2.9 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
0.1 | 4.5 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.1 | 0.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 7.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.1 | GO:0033646 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.3 | GO:0005792 | obsolete microsome(GO:0005792) |
0.1 | 0.2 | GO:0044437 | vacuolar membrane(GO:0005774) vacuolar part(GO:0044437) |
0.1 | 3.7 | GO:0005929 | cilium(GO:0005929) |
0.1 | 0.9 | GO:0031090 | organelle membrane(GO:0031090) |
0.1 | 2.0 | GO:0030141 | secretory granule(GO:0030141) |
0.1 | 5.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 7.9 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.1 | 1.6 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 0.1 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.1 | GO:0019867 | outer membrane(GO:0019867) |
0.1 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 101.0 | GO:0005622 | intracellular(GO:0005622) |
0.1 | 166.1 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.1 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.1 | 5.0 | GO:0071944 | cell periphery(GO:0071944) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 7.7 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
1.8 | 5.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.6 | 1.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.6 | 4.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
1.4 | 4.3 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
1.4 | 4.3 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.3 | 3.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.3 | 1.3 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
1.3 | 3.8 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
1.3 | 1.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
1.2 | 3.7 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
1.2 | 4.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.2 | 3.6 | GO:0050693 | LBD domain binding(GO:0050693) |
1.2 | 3.5 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
1.1 | 3.2 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
1.1 | 1.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.1 | 4.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
1.0 | 3.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.0 | 3.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
1.0 | 5.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
1.0 | 8.9 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
1.0 | 2.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.0 | 1.0 | GO:0003785 | actin monomer binding(GO:0003785) |
1.0 | 2.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.0 | 5.8 | GO:0005521 | lamin binding(GO:0005521) |
1.0 | 3.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.9 | 2.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.9 | 0.9 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.9 | 0.9 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.9 | 2.8 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.9 | 3.7 | GO:0045569 | TRAIL binding(GO:0045569) |
0.9 | 2.7 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.9 | 1.8 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.9 | 2.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.9 | 2.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.9 | 3.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.8 | 2.5 | GO:0031014 | troponin T binding(GO:0031014) |
0.8 | 9.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.8 | 3.3 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.8 | 5.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.8 | 2.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.8 | 3.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.8 | 2.5 | GO:0008061 | chitin binding(GO:0008061) |
0.8 | 4.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.8 | 4.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.8 | 3.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.8 | 2.3 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.8 | 8.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.8 | 6.2 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.8 | 0.8 | GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen(GO:0016705) |
0.7 | 3.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.7 | 3.7 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.7 | 2.2 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.7 | 2.9 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.7 | 4.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.7 | 1.5 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.7 | 2.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.7 | 2.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.7 | 2.9 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.7 | 5.7 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.7 | 2.1 | GO:0016829 | lyase activity(GO:0016829) |
0.7 | 4.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.7 | 4.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.7 | 8.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.7 | 4.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.7 | 2.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.7 | 2.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.7 | 1.4 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.7 | 2.7 | GO:0030172 | troponin C binding(GO:0030172) |
0.7 | 4.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.7 | 2.0 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.7 | 2.7 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.6 | 3.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.6 | 6.5 | GO:0030276 | clathrin binding(GO:0030276) |
0.6 | 1.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.6 | 1.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.6 | 3.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.6 | 3.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.6 | 2.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.6 | 2.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.6 | 9.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.6 | 2.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.6 | 3.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.6 | 3.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.6 | 1.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.6 | 2.4 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.6 | 2.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.6 | 1.8 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.6 | 2.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.6 | 1.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.6 | 1.2 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.6 | 1.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.6 | 8.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.6 | 1.7 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.6 | 2.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.6 | 1.1 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.6 | 1.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.6 | 0.6 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.6 | 0.6 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.6 | 4.4 | GO:0030371 | translation repressor activity(GO:0030371) |
0.6 | 2.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.5 | 1.6 | GO:0004875 | complement receptor activity(GO:0004875) |
0.5 | 2.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.5 | 1.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.5 | 2.2 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.5 | 3.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.5 | 3.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.5 | 4.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.5 | 8.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.5 | 1.1 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.5 | 6.9 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.5 | 5.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.5 | 3.7 | GO:0070888 | E-box binding(GO:0070888) |
0.5 | 3.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.5 | 3.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.5 | 1.6 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.5 | 4.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.5 | 3.1 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.5 | 5.2 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.5 | 1.6 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.5 | 1.6 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.5 | 1.6 | GO:0051425 | PTB domain binding(GO:0051425) |
0.5 | 2.6 | GO:0044620 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.5 | 1.6 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.5 | 2.1 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.5 | 1.6 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.5 | 9.3 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.5 | 8.2 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.5 | 5.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.5 | 1.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.5 | 3.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.5 | 1.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.5 | 2.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.5 | 0.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.5 | 5.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.5 | 1.0 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.5 | 1.9 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.5 | 3.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.5 | 2.9 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.5 | 5.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.5 | 2.4 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.5 | 7.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.5 | 3.8 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.5 | 1.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.5 | 1.4 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.5 | 7.0 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.5 | 0.5 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.5 | 2.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.5 | 2.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.5 | 1.4 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.5 | 0.9 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.5 | 3.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.5 | 1.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.5 | 1.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.5 | 16.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.5 | 5.9 | GO:0045296 | cadherin binding(GO:0045296) |
0.5 | 1.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 4.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.4 | 20.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.4 | 1.8 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.4 | 2.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.4 | 4.5 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.4 | 1.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 1.3 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.4 | 1.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.4 | 2.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.4 | 2.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.4 | 4.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.4 | 4.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.4 | 1.7 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
0.4 | 1.3 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.4 | 2.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 1.7 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.4 | 3.5 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.4 | 0.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.4 | 2.1 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.4 | 1.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.4 | 1.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.4 | 2.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 0.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.4 | 1.3 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.4 | 1.7 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.4 | 0.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.4 | 0.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.4 | 1.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.4 | 4.1 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.4 | 2.5 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.4 | 1.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.4 | 1.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.4 | 3.7 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.4 | 2.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.4 | 1.6 | GO:0034618 | arginine binding(GO:0034618) |
0.4 | 1.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.4 | 2.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.4 | 4.4 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.4 | 0.4 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.4 | 0.4 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.4 | 1.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.4 | 1.2 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.4 | 1.2 | GO:0035173 | histone kinase activity(GO:0035173) |
0.4 | 0.8 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.4 | 2.0 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.4 | 1.2 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.4 | 9.1 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.4 | 3.9 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.4 | 2.8 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.4 | 3.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 0.8 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.4 | 1.2 | GO:0005534 | galactose binding(GO:0005534) |
0.4 | 4.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.4 | 2.0 | GO:0005499 | vitamin D binding(GO:0005499) |
0.4 | 2.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.4 | 1.2 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.4 | 1.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.4 | 3.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.4 | 1.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.4 | 2.7 | GO:0019201 | nucleotide kinase activity(GO:0019201) |
0.4 | 3.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.4 | 1.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.4 | 2.7 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.4 | 8.8 | GO:0019843 | rRNA binding(GO:0019843) |
0.4 | 3.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.4 | 6.8 | GO:0043022 | ribosome binding(GO:0043022) |
0.4 | 9.9 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.4 | 1.5 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.4 | 4.2 | GO:0010181 | FMN binding(GO:0010181) |
0.4 | 1.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.4 | 3.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.4 | 1.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.4 | 1.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.4 | 0.7 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.4 | 11.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.4 | 0.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.4 | 7.3 | GO:0030145 | manganese ion binding(GO:0030145) |
0.4 | 0.7 | GO:0034648 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.4 | 10.2 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
0.4 | 1.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.4 | 0.4 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.4 | 1.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.4 | 5.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 1.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.4 | 1.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.4 | 6.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.4 | 0.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.4 | 1.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.4 | 1.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.4 | 1.1 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.4 | 8.8 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.3 | 1.0 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.3 | 1.4 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 2.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.3 | 1.4 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.3 | 2.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 1.7 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.3 | 0.7 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.3 | 2.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 2.4 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.3 | 11.3 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.3 | 1.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 0.7 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.3 | 1.7 | GO:0052742 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) phosphatidylinositol kinase activity(GO:0052742) |
0.3 | 3.8 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.3 | 1.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 2.4 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.3 | 5.8 | GO:0004675 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) |
0.3 | 1.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 3.4 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.3 | 1.4 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.3 | 1.0 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.3 | 1.3 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.3 | 1.0 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.3 | 0.3 | GO:0048156 | tau protein binding(GO:0048156) |
0.3 | 3.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 1.3 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.3 | 1.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.3 | 0.7 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.3 | 3.0 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.3 | 1.3 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.3 | 2.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 1.6 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.3 | 1.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.3 | 0.7 | GO:0043176 | amine binding(GO:0043176) |
0.3 | 14.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 2.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 1.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 1.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.3 | 0.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.3 | 1.0 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.3 | 2.2 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.3 | 24.7 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.3 | 1.9 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 1.9 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 2.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 2.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 2.5 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.3 | 0.9 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.3 | 0.9 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 0.6 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 5.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 1.2 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.3 | 0.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 5.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.3 | 0.9 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.3 | 1.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.3 | 4.2 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.3 | 0.6 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.3 | 0.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 1.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 0.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 3.8 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.3 | 2.7 | GO:0030515 | snoRNA binding(GO:0030515) |
0.3 | 1.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 0.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 1.8 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.3 | 2.9 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.3 | 2.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.3 | 0.9 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.3 | 1.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.3 | 0.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.3 | 1.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.3 | 1.7 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 0.9 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.3 | 2.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.3 | 0.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 0.9 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.3 | 4.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.3 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.3 | 0.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.3 | 0.8 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.3 | 1.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 1.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.3 | 0.8 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.3 | 1.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 0.6 | GO:0046332 | SMAD binding(GO:0046332) |
0.3 | 5.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.3 | 0.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.3 | 0.8 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.3 | 3.6 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.3 | 7.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 0.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 0.5 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.3 | 1.1 | GO:0070513 | death domain binding(GO:0070513) |
0.3 | 1.1 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.3 | 0.5 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.3 | 3.3 | GO:0005035 | death receptor activity(GO:0005035) |
0.3 | 1.3 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 7.0 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.3 | 0.5 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.3 | 5.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 0.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.3 | 0.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 1.9 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.3 | 0.5 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 1.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.3 | 0.5 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.3 | 0.3 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.3 | 7.1 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.3 | 9.5 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.3 | 2.9 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.3 | 1.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.3 | 2.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.3 | 0.5 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.3 | 7.3 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.3 | 2.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.3 | 4.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.3 | 1.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.3 | 0.3 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) peptide-transporting ATPase activity(GO:0015440) |
0.3 | 15.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.3 | 1.0 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.3 | 1.3 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 0.8 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.3 | 1.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 1.3 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.3 | 1.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.3 | 3.1 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.3 | 2.0 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.3 | 0.8 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 0.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 3.5 | GO:0043621 | protein self-association(GO:0043621) |
0.2 | 1.7 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 0.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.2 | 2.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 5.2 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 1.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 0.5 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.2 | 35.5 | GO:0016564 | obsolete transcription repressor activity(GO:0016564) |
0.2 | 0.5 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 1.5 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.2 | 1.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 16.2 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.2 | 6.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 1.2 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.2 | 6.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 0.5 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.2 | 1.2 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.2 | 0.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 3.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 1.9 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.2 | 0.5 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.2 | 0.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 0.2 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.2 | 0.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 1.9 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 1.4 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.2 | 1.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.2 | 2.6 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.2 | 2.8 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 0.7 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 4.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 0.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.2 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.5 | GO:0042806 | fucose binding(GO:0042806) |
0.2 | 1.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 0.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.2 | 37.5 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.2 | 5.7 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 1.4 | GO:0061659 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.2 | 0.5 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 7.4 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 1.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 3.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 0.9 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.2 | 7.8 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.2 | 0.4 | GO:0019956 | chemokine binding(GO:0019956) |
0.2 | 0.9 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.2 | 0.4 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.2 | 4.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 1.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.9 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 3.2 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.2 | 1.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 0.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 2.4 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 0.6 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 0.9 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
0.2 | 0.2 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.2 | 2.3 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.2 | 0.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 0.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 1.1 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 0.4 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.2 | 0.8 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 3.8 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.2 | 1.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 1.0 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.2 | 0.2 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 0.8 | GO:0017069 | snRNA binding(GO:0017069) |
0.2 | 1.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 11.5 | GO:0016741 | transferase activity, transferring one-carbon groups(GO:0016741) |
0.2 | 1.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 1.7 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 0.4 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.2 | 0.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 1.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 1.4 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 0.2 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.2 | 2.9 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 0.4 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 1.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 0.8 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.2 | 34.2 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.2 | 3.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 0.6 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 0.6 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 3.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 1.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) cis-trans isomerase activity(GO:0016859) |
0.2 | 0.4 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.2 | 2.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 0.6 | GO:0032451 | demethylase activity(GO:0032451) |
0.2 | 40.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 5.7 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.2 | 0.4 | GO:0015926 | glucosidase activity(GO:0015926) |
0.2 | 1.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.8 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.2 | 0.8 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 0.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 1.0 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 1.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.2 | 0.4 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.2 | 1.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.2 | 0.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 0.6 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.2 | 2.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 1.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 0.4 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 1.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 0.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.6 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.2 | 53.6 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.2 | 0.9 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.2 | 0.8 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.2 | 2.4 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.2 | 0.6 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.2 | 2.1 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 0.6 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.2 | 1.3 | GO:0030553 | cGMP binding(GO:0030553) |
0.2 | 1.7 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 0.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 3.3 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.2 | 2.5 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.2 | 5.7 | GO:0005506 | iron ion binding(GO:0005506) |
0.2 | 0.5 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 0.7 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.2 | 0.9 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 0.2 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.2 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 0.9 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
0.2 | 215.8 | GO:0003677 | DNA binding(GO:0003677) |
0.2 | 0.4 | GO:0004386 | helicase activity(GO:0004386) |
0.2 | 0.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.2 | 0.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 3.1 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.2 | 1.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.2 | 1.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.2 | 1.0 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.2 | 1.0 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 1.0 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.2 | 0.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 0.9 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.2 | 2.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 0.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 0.5 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 1.4 | GO:0060589 | nucleoside-triphosphatase regulator activity(GO:0060589) |
0.2 | 0.3 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.2 | 6.4 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.2 | 0.3 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.2 | 0.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 0.7 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.2 | 0.5 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 0.2 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.2 | 1.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 0.5 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.3 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 13.3 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.2 | 2.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 3.6 | GO:0051287 | NAD binding(GO:0051287) |
0.2 | 2.3 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.2 | 2.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.2 | 0.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 5.9 | GO:0008017 | microtubule binding(GO:0008017) |
0.2 | 1.0 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 1.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 1.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 1.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 1.0 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.2 | 3.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 0.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 0.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 1.8 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 1.5 | GO:0051117 | ATPase binding(GO:0051117) |
0.2 | 1.1 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 0.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 0.3 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.2 | 0.2 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.2 | 0.5 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.2 | 2.4 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 1.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 3.2 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 0.4 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 0.1 | GO:0004529 | exodeoxyribonuclease activity(GO:0004529) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
0.1 | 4.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 1.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.6 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.4 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 0.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.6 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 38.3 | GO:0032561 | GTP binding(GO:0005525) guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.1 | 0.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 3.0 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.4 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 1.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.4 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.6 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 1.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 4.8 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 7.2 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 0.6 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 5.5 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 2.2 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 6.1 | GO:0004519 | endonuclease activity(GO:0004519) |
0.1 | 4.5 | GO:0016791 | phosphatase activity(GO:0016791) |
0.1 | 1.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 6.0 | GO:0050662 | coenzyme binding(GO:0050662) |
0.1 | 0.4 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 3.5 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 0.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 3.0 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.3 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 15.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 3.3 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 0.6 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 0.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 1.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 1.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.4 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 0.9 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 4.3 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 2.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.1 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 2.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 53.2 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.1 | 0.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 1.1 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.1 | 0.9 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.8 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.1 | 1.5 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 3.3 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 0.1 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 1.0 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 6.3 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.1 | 1.9 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 0.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.1 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 1.1 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.9 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.1 | 0.1 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.1 | 0.2 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.1 | 0.7 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.1 | 1.5 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.1 | 0.2 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.1 | 0.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.4 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 1.2 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.1 | 0.4 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.1 | 0.8 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.3 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 1.4 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 0.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 2.0 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 49.3 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.1 | 0.2 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.1 | 1.4 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 11.8 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 0.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 0.6 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.1 | 0.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.8 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 3.7 | GO:0017111 | nucleoside-triphosphatase activity(GO:0017111) |
0.1 | 14.5 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 1.0 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.1 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 1.5 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 1.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.5 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.7 | GO:0005343 | organic acid:sodium symporter activity(GO:0005343) |
0.1 | 8.5 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 1.2 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.1 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 1.6 | GO:0044389 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.1 | 0.5 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.1 | 0.4 | GO:0004518 | nuclease activity(GO:0004518) |
0.1 | 0.2 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 3.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 2.7 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.1 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.1 | 2.8 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 6.2 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 9.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 1.0 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.9 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.2 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.1 | 0.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.1 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.1 | 1.9 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.1 | 0.3 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.9 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 1.2 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 1.4 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 0.3 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 0.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.7 | GO:0016817 | hydrolase activity, acting on acid anhydrides(GO:0016817) |
0.1 | 1.8 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 0.2 | GO:0019829 | cation-transporting ATPase activity(GO:0019829) |
0.1 | 0.5 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.8 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.1 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 12.8 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.3 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.1 | 0.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.3 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.1 | 0.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.2 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.2 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.4 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.7 | GO:0019838 | growth factor binding(GO:0019838) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.1 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.0 | 0.2 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.0 | 0.2 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.0 | 0.2 | GO:0015450 | protein transmembrane transporter activity(GO:0008320) P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) macromolecule transmembrane transporter activity(GO:0022884) |
0.0 | 90.7 | GO:0005515 | protein binding(GO:0005515) |
0.0 | 0.2 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.0 | 0.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.0 | GO:0016209 | antioxidant activity(GO:0016209) |
0.0 | 1.5 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.2 | GO:0015250 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.0 | 0.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.0 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.0 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.0 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.0 | 0.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 3.9 | GO:0016787 | hydrolase activity(GO:0016787) |
0.0 | 0.0 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 13.8 | GO:0005488 | binding(GO:0005488) |
0.0 | 0.0 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.1 | GO:0005230 | extracellular ligand-gated ion channel activity(GO:0005230) |
0.0 | 0.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.1 | GO:0038024 | cargo receptor activity(GO:0038024) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 2.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.8 | 4.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.8 | 2.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.6 | 6.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.6 | 4.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.6 | 9.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.6 | 3.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.5 | 15.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.5 | 5.5 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.5 | 0.5 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.5 | 2.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.5 | 6.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 10.3 | PID EPO PATHWAY | EPO signaling pathway |
0.5 | 2.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 12.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.5 | 13.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.5 | 13.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.5 | 14.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.5 | 5.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.5 | 15.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.5 | 6.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.4 | 11.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.4 | 13.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.4 | 9.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.4 | 10.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.4 | 5.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 15.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.4 | 11.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.4 | 11.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.4 | 5.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 16.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.4 | 8.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 4.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.4 | 2.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.4 | 5.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.4 | 0.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.4 | 17.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.4 | 10.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 14.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.4 | 4.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.4 | 19.1 | PID P73PATHWAY | p73 transcription factor network |
0.4 | 11.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.4 | 4.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.4 | 0.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.4 | 7.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.4 | 20.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.4 | 13.3 | PID BMP PATHWAY | BMP receptor signaling |
0.4 | 4.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.4 | 1.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 1.8 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 1.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.4 | 1.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 1.7 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 2.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 2.9 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 2.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 2.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.3 | 3.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.3 | 6.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 10.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 4.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 5.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.3 | 9.9 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 2.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 1.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 2.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 1.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 3.3 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 3.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 4.5 | PID ATM PATHWAY | ATM pathway |
0.3 | 7.0 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 1.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.2 | 4.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 2.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 4.6 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 3.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 4.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 4.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 0.9 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 3.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 2.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 3.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 4.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 1.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 5.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 2.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 4.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 5.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 5.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 2.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 1.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 6.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 4.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.2 | 4.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 1.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 1.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 1.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 1.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 2.8 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 3.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 0.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 2.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 1.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 4.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 1.1 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 2.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 20.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 3.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 1.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 1.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 1.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 2.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 5.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 2.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.4 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 1.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 1.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.0 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 1.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
1.0 | 3.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.9 | 0.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.9 | 5.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.8 | 3.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.8 | 1.6 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
0.8 | 10.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.8 | 0.8 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.7 | 3.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.7 | 28.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.7 | 2.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.7 | 0.7 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.7 | 3.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.7 | 4.0 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.6 | 13.6 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.6 | 7.1 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.6 | 8.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.6 | 5.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.6 | 7.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.6 | 3.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.6 | 1.9 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.6 | 5.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.6 | 13.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.6 | 5.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.6 | 7.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.5 | 0.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.5 | 0.5 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.5 | 1.6 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.5 | 6.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.5 | 8.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.5 | 11.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.5 | 5.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.5 | 6.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.5 | 8.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.5 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.5 | 4.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.5 | 15.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.5 | 7.6 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.5 | 0.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.5 | 1.9 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.5 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.5 | 5.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.5 | 8.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.5 | 13.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.4 | 3.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 5.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 11.4 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.4 | 6.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.4 | 4.3 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.4 | 4.6 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.4 | 4.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 7.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.4 | 7.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.4 | 2.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.4 | 9.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.4 | 6.8 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.4 | 1.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.4 | 11.5 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.4 | 3.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.4 | 6.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.4 | 1.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.4 | 6.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.4 | 2.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 6.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.4 | 4.0 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.4 | 2.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 7.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 3.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 1.7 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.3 | 0.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 4.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 2.0 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.3 | 5.0 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.3 | 5.0 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.3 | 5.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.3 | 4.9 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.3 | 2.9 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.3 | 2.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 3.8 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.3 | 21.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 4.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 4.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.3 | 1.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.3 | 1.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.3 | 2.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.3 | 0.9 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.3 | 1.2 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.3 | 9.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 0.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 3.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 15.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.3 | 0.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.3 | 3.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 0.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 13.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.3 | 2.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 5.5 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.3 | 2.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.3 | 3.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.3 | 3.0 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 2.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.3 | 3.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.3 | 4.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.3 | 5.8 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.3 | 3.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 0.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.3 | 2.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.3 | 3.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.3 | 17.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.3 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.3 | 4.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 10.3 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.3 | 3.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 2.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.3 | 63.4 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.3 | 0.5 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.3 | 3.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 3.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 0.5 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 3.2 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 4.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 10.4 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.2 | 4.1 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.2 | 4.1 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.2 | 0.5 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 3.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 2.3 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.2 | 2.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 4.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 2.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 2.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 5.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 0.5 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.2 | 11.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 1.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 1.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 5.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 0.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 1.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 5.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 1.3 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.2 | 1.5 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.2 | 0.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 4.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 2.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 0.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 2.9 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 4.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 2.5 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.2 | 4.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 1.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.2 | 9.5 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.2 | 0.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 0.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.2 | 4.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 1.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 9.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 13.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 5.9 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 7.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 1.9 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.2 | 10.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 2.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 4.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 1.6 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.2 | 0.5 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 1.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 2.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 3.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.2 | 2.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 5.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 10.3 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.2 | 1.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 0.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 0.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 2.5 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.2 | 2.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 0.8 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 2.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 8.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 9.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.2 | 2.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 18.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 1.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 2.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 1.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 1.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 0.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 0.8 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 2.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.2 | 2.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 0.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 5.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 1.1 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.2 | 0.6 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 13.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 1.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 1.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 5.6 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.1 | 1.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 9.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 4.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 1.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 6.8 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 0.9 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 1.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 3.1 | REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | Genes involved in Post-translational protein modification |
0.1 | 2.1 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 1.2 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.1 | 5.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 1.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 0.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 1.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 2.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 1.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 1.6 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.1 | 1.1 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 1.5 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 0.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 0.5 | REACTOME S PHASE | Genes involved in S Phase |
0.1 | 0.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 2.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.5 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.1 | 1.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 2.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 2.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.4 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.1 | 2.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 3.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.4 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.1 | 4.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 11.7 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.1 | 5.5 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 1.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.3 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 1.1 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.1 | 3.3 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 1.0 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 4.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.3 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.1 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.1 | 1.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 1.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.0 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 1.1 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 0.5 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.1 | 0.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.5 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.0 | 0.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 1.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.3 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.4 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.0 | 0.1 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.0 | 2.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.3 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.5 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.0 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.0 | 0.0 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 0.1 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |